activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650207	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1650207	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1650208	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1650209	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1650210	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1650211	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1650212	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1650213	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL2543	Homo sapiens	Kd		
	1650214	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Kd	nM	1400.0	CHEMBL2543	Homo sapiens	Kd	uM	1.4
Not Active	1650215	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL2543	Homo sapiens	Kd		
	1652083	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1400.0	CHEMBL2543	Homo sapiens	Kd	uM	1.4
Not Active	1652084	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1652085	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1652086	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1652087	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1652088	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1652089	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1652090	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1652091	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1652092	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL2543	Homo sapiens	Kd		
Not Active	1652093	CHEMBL860892	Average Binding Constant for CSNK1G2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL2543	Homo sapiens	Kd		
	2051612	CHEMBL941750	Inhibition of CK1gamma 2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	7166.0	CHEMBL2543	Homo sapiens	Ki	uM	7.166
	2147220	CHEMBL929099	Activity of human CK1gamma2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	116.0	CHEMBL2543	Homo sapiens	Activity	%	116.0
	2182806	CHEMBL941433	Inhibition of CSNK1G2 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	2.0	CHEMBL2543	Homo sapiens	INH	%	2.0
	2470140	CHEMBL1034089	Inhibition of CSNK1G2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2543	Homo sapiens	INH	%	10.0
	2512013	CHEMBL970582	Inhibition of CK1gamma2 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	10.0	CHEMBL2543	Homo sapiens	INH	%	10.0
	2721576	CHEMBL1060984	Inhibition of CK1gamma2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	2892385	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892386	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892387	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	950.0	CHEMBL2543	Homo sapiens	Kd	nM	950.0
	2892388	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892389	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892390	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892391	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892392	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892393	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892394	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892395	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892396	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892397	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892398	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892399	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892400	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892401	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892402	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892403	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892404	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	740.0	CHEMBL2543	Homo sapiens	Kd	nM	740.0
	2892405	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892406	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892407	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892408	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892409	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892410	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892411	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892412	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892413	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892414	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892415	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892416	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892417	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	780.0	CHEMBL2543	Homo sapiens	Kd	nM	780.0
	2892418	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	790.0	CHEMBL2543	Homo sapiens	Kd	nM	790.0
	2892419	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	110.0	CHEMBL2543	Homo sapiens	Kd	nM	110.0
	2892420	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892421	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2892422	CHEMBL1063704	Binding constant for full-length CSNK1G2	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	2921388	CHEMBL1052904	Inhibition of CSNK1G2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2543	Homo sapiens	Activity	%	100.0
	2992201	CHEMBL1044504	Inhibition of human CK1gamma2 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	36.0	CHEMBL2543	Homo sapiens	INH	%	36.0
	2995389	CHEMBL1039039	Binding affinity to CSNK1G2 assessed as dissociation constant	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Kd	nM	270.0	CHEMBL2543	Homo sapiens	Kd	nM	270.0
	3052568	CHEMBL1037109	Residual activity of CK1gamma2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	100.0	CHEMBL2543	Homo sapiens	Residual activity	%	100.0
	3053877	CHEMBL1044277	Residual activity of CK1gamma2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	226.0	CHEMBL2543	Homo sapiens	Residual activity	%	226.0
	3054129	CHEMBL1066647	Residual activity of CK1gamma2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	93.0	CHEMBL2543	Homo sapiens	Residual activity	%	93.0
	3055416	CHEMBL1037109	Residual activity of CK1gamma2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	98.0	CHEMBL2543	Homo sapiens	Residual activity	%	98.0
	3055668	CHEMBL1044277	Residual activity of CK1gamma2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	217.0	CHEMBL2543	Homo sapiens	Residual activity	%	217.0
	3056973	CHEMBL1066647	Residual activity of CK1gamma2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	93.0	CHEMBL2543	Homo sapiens	Residual activity	%	93.0
	3058293	CHEMBL1037109	Residual activity of CK1gamma2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	107.0	CHEMBL2543	Homo sapiens	Residual activity	%	107.0
	3058545	CHEMBL1044277	Residual activity of CK1gamma2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	198.0	CHEMBL2543	Homo sapiens	Residual activity	%	198.0
	3062456	CHEMBL1048649	Binding affinity to human CSNK1G2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL2543	Homo sapiens	Activity	%	100.0
	3063591	CHEMBL1039788	Binding affinity to human CSNK1G2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	99.0	CHEMBL2543	Homo sapiens	Activity	%	99.0
	3063681	CHEMBL1038892	Binding affinity to human CSNK1G2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL2543	Homo sapiens	Activity	%	100.0
	3065861	CHEMBL1069293	Inhibition of CSNK1G2 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL2543	Homo sapiens	INH	%	0.0
	3066927	CHEMBL1069293	Inhibition of CSNK1G2 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL2543	Homo sapiens	INH	%	0.0
	3072891	CHEMBL1066647	Residual activity of CK1gamma2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL2543	Homo sapiens	Residual activity	%	90.0
	3213905	CHEMBL1114861	Inhibition of CK1gamma2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	1.0	CHEMBL2543	Homo sapiens	INH	%	1.0
	3224790	CHEMBL1102784	Inhibition of CSNK1G2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3225040	CHEMBL1102784	Inhibition of CSNK1G2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3331883	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3333298	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3334703	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3336123	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3337490	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3337738	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3339070	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3340372	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3340651	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3342067	CHEMBL1168842	Inhibition of CSNK1G2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	3358516	CHEMBL1174188	Inhibition of CSNK1G2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL2543	Homo sapiens	INH	%	100.0
	3358958	CHEMBL1174188	Inhibition of CSNK1G2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	14.0	CHEMBL2543	Homo sapiens	INH	%	14.0
	3443369	CHEMBL1244402	Inhibition of CK1gamma2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	2.0	CHEMBL2543	Homo sapiens	INH	%	2.0
	3443586	CHEMBL1244402	Inhibition of CK1gamma2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	1.0	CHEMBL2543	Homo sapiens	INH	%	1.0
	3444741	CHEMBL1244402	Inhibition of CK1gamma2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	-7.0	CHEMBL2543	Homo sapiens	INH	%	-7.0
	3445365	CHEMBL1244402	Inhibition of CK1gamma2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	0.0	CHEMBL2543	Homo sapiens	INH	%	0.0
	3445582	CHEMBL1244402	Inhibition of CK1gamma2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	12.0	CHEMBL2543	Homo sapiens	INH	%	12.0
	3445794	CHEMBL1244402	Inhibition of CK1gamma2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	14.0	CHEMBL2543	Homo sapiens	INH	%	14.0
	3445984	CHEMBL1244402	Inhibition of CK1gamma2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	4.0	CHEMBL2543	Homo sapiens	INH	%	4.0
	3448388	CHEMBL1244780	Binding affinity to CSNK1G2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	3448723	CHEMBL1244780	Binding affinity to CSNK1G2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	3449142	CHEMBL1244780	Binding affinity to CSNK1G2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	110.0	CHEMBL2543	Homo sapiens	Kd	nM	110.0
	3449615	CHEMBL1244780	Binding affinity to CSNK1G2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	3449920	CHEMBL1244780	Binding affinity to CSNK1G2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	3450037	CHEMBL1244780	Binding affinity to CSNK1G2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	3450956	CHEMBL1244780	Binding affinity to CSNK1G2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	uM	10.0
	3463202	CHEMBL1252290	Inhibition of CSNK1G2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	81.0	CHEMBL2543	Homo sapiens	INH	%	81.0
	3463421	CHEMBL1252290	Inhibition of CSNK1G2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	12.0	CHEMBL2543	Homo sapiens	INH	%	12.0
	3463965	CHEMBL1252290	Inhibition of CSNK1G2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	15.0	CHEMBL2543	Homo sapiens	INH	%	15.0
	5120306	CHEMBL1648367	Inhibition of human CK1gamma2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	99.0	CHEMBL2543	Homo sapiens	INH	%	99.0
	6165970	CHEMBL1768717	Binding affinity to CSNK1G2 at 10 uM by high-throughput binding assay relative to control	B	Cc1nc(-c2cnc3ccc(-c4cncc(NS(=O)(=O)c5ccccc5)c4)cn23)no1		CHEMBL1765464	=	Activity	%	0.55	CHEMBL2543	Homo sapiens	Activity	%	0.55
	6218829	CHEMBL1786920	Binding affinity to human CSNK1G2 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	>	Activity	%	50.0	CHEMBL2543	Homo sapiens	Activity	%	50.0
Not Determined	6218855	CHEMBL1787159	Binding affinity to human CSNK1G2 incubated for 1 hr by kinase binding assay	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Kd			CHEMBL2543	Homo sapiens	Kd		
	6219033	CHEMBL1786920	Binding affinity to human CSNK1G2 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1		CHEMBL1783929	=	Activity	%	18.0	CHEMBL2543	Homo sapiens	Activity	%	18.0
	6220382	CHEMBL1786920	Binding affinity to human CSNK1G2 at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1		CHEMBL1783930	=	Activity	%	43.0	CHEMBL2543	Homo sapiens	Activity	%	43.0
	6340965	CHEMBL1827289	Activity of CSNK1G2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	95.0	CHEMBL2543	Homo sapiens	Activity	%	95.0
	7567228	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7567687	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7568158	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7569201	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7569661	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7570133	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7570154	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7570581	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	110.0	CHEMBL2543	Homo sapiens	Kd	nM	110.0
	7571177	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	5700.0	CHEMBL2543	Homo sapiens	Kd	nM	5700.0
	7571634	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7572131	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7572547	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7573158	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7573649	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7574118	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7574526	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	2400.0	CHEMBL2543	Homo sapiens	Kd	nM	2400.0
	7575136	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7575155	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7575626	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7576091	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	4100.0	CHEMBL2543	Homo sapiens	Kd	nM	4100.0
	7576499	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7577127	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7577605	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	580.0	CHEMBL2543	Homo sapiens	Kd	nM	580.0
	7578075	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	3000.0	CHEMBL2543	Homo sapiens	Kd	nM	3000.0
	7578480	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7578676	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	380.0	CHEMBL2543	Homo sapiens	Kd	nM	380.0
	7579050	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7579500	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7579974	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7580443	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7580846	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7581034	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7581419	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7581864	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7582335	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7582799	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7583199	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7583380	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7583777	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7584222	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7584693	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7585710	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7586118	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7586564	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7587047	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7587671	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7588090	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7588543	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7588572	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7589023	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7589636	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7590060	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7590559	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7591010	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7591609	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	950.0	CHEMBL2543	Homo sapiens	Kd	nM	950.0
	7592061	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7592534	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7592987	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7593569	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7594041	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7594514	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7594966	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7595102	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7595546	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7596020	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7596491	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7596938	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	780.0	CHEMBL2543	Homo sapiens	Kd	nM	780.0
	7597074	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7597527	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7598000	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	6600.0	CHEMBL2543	Homo sapiens	Kd	nM	6600.0
	7598470	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2543	Homo sapiens	Kd	nM	10000.0
	7598912	CHEMBL1908530	Binding constant for CSNK1G2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	790.0	CHEMBL2543	Homo sapiens	Kd	nM	790.0
	7922651	CHEMBL1918997	Inhibition of human recombinant CK1gamma2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	83.0	CHEMBL2543	Homo sapiens	INH	%	83.0
	7982610	CHEMBL1936992	Inhibition of CSNK1G2 at 10 uM after 1 hr by competitive binding assay	B	CCOC(=O)C[C@@H]1[C@@H](CNC(=O)NC)O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@@H]1O[Si](C)(C)C(C)(C)C		CHEMBL1076310	=	Inhibition	%	38.0	CHEMBL2543	Homo sapiens	INH	%	38.0
	7992179	CHEMBL1935899	Inhibition of CK1 gamma 2 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	16.0	CHEMBL2543	Homo sapiens	INH	%	16.0
	8046129	CHEMBL1958838	Inhibition of CSNK1G2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	=	Inhibition	%	99.0	CHEMBL2543	Homo sapiens	INH	%	99.0
	8061288	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.27	CHEMBL2543	Homo sapiens	Inhibition	%	0.27
	8061465	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.09	CHEMBL2543	Homo sapiens	Inhibition	%	-3.09
	8061796	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	35.18	CHEMBL2543	Homo sapiens	Inhibition	%	35.18
	8061987	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.76	CHEMBL2543	Homo sapiens	Inhibition	%	1.76
	8062327	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.2	CHEMBL2543	Homo sapiens	Inhibition	%	2.2
	8062489	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.84	CHEMBL2543	Homo sapiens	Inhibition	%	2.84
	8062713	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.66	CHEMBL2543	Homo sapiens	Inhibition	%	3.66
	8062811	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.81	CHEMBL2543	Homo sapiens	Inhibition	%	0.81
	8063167	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.74	CHEMBL2543	Homo sapiens	Inhibition	%	2.74
	8063334	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.23	CHEMBL2543	Homo sapiens	Inhibition	%	1.23
	8063558	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.48	CHEMBL2543	Homo sapiens	Inhibition	%	1.48
	8063666	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.5	CHEMBL2543	Homo sapiens	Inhibition	%	1.5
	8063848	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.63	CHEMBL2543	Homo sapiens	Inhibition	%	3.63
	8064072	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.92	CHEMBL2543	Homo sapiens	Inhibition	%	1.92
	8064187	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.42	CHEMBL2543	Homo sapiens	Inhibition	%	3.42
	8064397	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.45	CHEMBL2543	Homo sapiens	Inhibition	%	1.45
	8064621	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.93	CHEMBL2543	Homo sapiens	Inhibition	%	5.93
	8064759	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.28	CHEMBL2543	Homo sapiens	Inhibition	%	0.28
	8065149	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.99	CHEMBL2543	Homo sapiens	Inhibition	%	1.99
	8065265	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.29	CHEMBL2543	Homo sapiens	Inhibition	%	3.29
	8065664	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.28	CHEMBL2543	Homo sapiens	Inhibition	%	3.28
	8065779	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.06	CHEMBL2543	Homo sapiens	Inhibition	%	1.06
	8066003	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.09	CHEMBL2543	Homo sapiens	Inhibition	%	1.09
	8066213	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.48	CHEMBL2543	Homo sapiens	Inhibition	%	0.48
	8066349	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.12	CHEMBL2543	Homo sapiens	Inhibition	%	4.12
	8066573	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.83	CHEMBL2543	Homo sapiens	Inhibition	%	3.83
	8066739	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.22	CHEMBL2543	Homo sapiens	Inhibition	%	1.22
	8066863	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.89	CHEMBL2543	Homo sapiens	Inhibition	%	0.89
	8067087	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.6	CHEMBL2543	Homo sapiens	Inhibition	%	1.6
	8067262	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.08	CHEMBL2543	Homo sapiens	Inhibition	%	1.08
	8067607	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.65	CHEMBL2543	Homo sapiens	Inhibition	%	1.65
	8067817	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.36	CHEMBL2543	Homo sapiens	Inhibition	%	3.36
	8068176	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	39.3	CHEMBL2543	Homo sapiens	Inhibition	%	39.3
	8068340	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.82	CHEMBL2543	Homo sapiens	Inhibition	%	1.82
	8068689	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.66	CHEMBL2543	Homo sapiens	Inhibition	%	0.66
	8068863	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.81	CHEMBL2543	Homo sapiens	Inhibition	%	2.81
	8069212	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	7.48	CHEMBL2543	Homo sapiens	Inhibition	%	7.48
	8069507	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	20.79	CHEMBL2543	Homo sapiens	Inhibition	%	20.79
	8069668	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.13	CHEMBL2543	Homo sapiens	Inhibition	%	2.13
	8069892	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.66	CHEMBL2543	Homo sapiens	Inhibition	%	1.66
	8070018	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.5	CHEMBL2543	Homo sapiens	Inhibition	%	0.5
	8070190	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.0	CHEMBL2543	Homo sapiens	Inhibition	%	2.0
	8070414	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.6	CHEMBL2543	Homo sapiens	Inhibition	%	2.6
	8070539	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.19	CHEMBL2543	Homo sapiens	Inhibition	%	0.19
	8070837	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	76.8	CHEMBL2543	Homo sapiens	Inhibition	%	76.8
	8071218	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.54	CHEMBL2543	Homo sapiens	Inhibition	%	1.54
	8071344	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.55	CHEMBL2543	Homo sapiens	Inhibition	%	0.55
	8071741	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.3	CHEMBL2543	Homo sapiens	Inhibition	%	2.3
	8071866	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.17	CHEMBL2543	Homo sapiens	Inhibition	%	1.17
	8072090	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.36	CHEMBL2543	Homo sapiens	Inhibition	%	-0.36
	8072180	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.21	CHEMBL2543	Homo sapiens	Inhibition	%	-0.21
	8072561	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.17	CHEMBL2543	Homo sapiens	Inhibition	%	2.17
	8072686	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.49	CHEMBL2543	Homo sapiens	Inhibition	%	0.49
	8072910	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.13	CHEMBL2543	Homo sapiens	Inhibition	%	0.13
	8073077	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.51	CHEMBL2543	Homo sapiens	Inhibition	%	2.51
	8073426	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.08	CHEMBL2543	Homo sapiens	Inhibition	%	-0.08
	8073545	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.31	CHEMBL2543	Homo sapiens	Inhibition	%	0.31
	8073778	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.35	CHEMBL2543	Homo sapiens	Inhibition	%	-0.35
	8074002	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.27	CHEMBL2543	Homo sapiens	Inhibition	%	-0.27
	8074154	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.9	CHEMBL2543	Homo sapiens	Inhibition	%	1.9
	8074508	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.02	CHEMBL2543	Homo sapiens	Inhibition	%	0.02
	8074665	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.59	CHEMBL2543	Homo sapiens	Inhibition	%	3.59
	8075016	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.25	CHEMBL2543	Homo sapiens	Inhibition	%	-1.25
	8075127	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.86	CHEMBL2543	Homo sapiens	Inhibition	%	0.86
	8075351	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.74	CHEMBL2543	Homo sapiens	Inhibition	%	1.74
	8075588	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.03	CHEMBL2543	Homo sapiens	Inhibition	%	0.03
	8075729	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.25	CHEMBL2543	Homo sapiens	Inhibition	%	2.25
	8076095	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.92	CHEMBL2543	Homo sapiens	Inhibition	%	-0.92
	8076243	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	10.5	CHEMBL2543	Homo sapiens	Inhibition	%	10.5
	8076467	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.92	CHEMBL2543	Homo sapiens	Inhibition	%	2.92
	8076601	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.47	CHEMBL2543	Homo sapiens	Inhibition	%	-1.47
	8076927	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.86	CHEMBL2543	Homo sapiens	Inhibition	%	0.86
	8077174	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.78	CHEMBL2543	Homo sapiens	Inhibition	%	-0.78
	8077302	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.4	CHEMBL2543	Homo sapiens	Inhibition	%	3.4
	8077526	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.7	CHEMBL2543	Homo sapiens	Inhibition	%	1.7
	8077677	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.54	CHEMBL2543	Homo sapiens	Inhibition	%	-0.54
	8078044	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	7.82	CHEMBL2543	Homo sapiens	Inhibition	%	7.82
	8078183	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.44	CHEMBL2543	Homo sapiens	Inhibition	%	-1.44
	8078509	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.32	CHEMBL2543	Homo sapiens	Inhibition	%	1.32
	8078759	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	4.43	CHEMBL2543	Homo sapiens	Inhibition	%	4.43
	8079099	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.54	CHEMBL2543	Homo sapiens	Inhibition	%	1.54
	8079257	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.3	CHEMBL2543	Homo sapiens	Inhibition	%	-1.3
	8079623	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.93	CHEMBL2543	Homo sapiens	Inhibition	%	1.93
	8079762	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.15	CHEMBL2543	Homo sapiens	Inhibition	%	2.15
	8079986	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	20.88	CHEMBL2543	Homo sapiens	Inhibition	%	20.88
	8080091	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.04	CHEMBL2543	Homo sapiens	Inhibition	%	1.04
	8080343	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-1.09	CHEMBL2543	Homo sapiens	Inhibition	%	-1.09
	8080682	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.66	CHEMBL2543	Homo sapiens	Inhibition	%	1.66
	8080846	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.43	CHEMBL2543	Homo sapiens	Inhibition	%	-0.43
	8081070	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.89	CHEMBL2543	Homo sapiens	Inhibition	%	-1.89
	8081205	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.2	CHEMBL2543	Homo sapiens	Inhibition	%	3.2
	8081573	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	72.66	CHEMBL2543	Homo sapiens	Inhibition	%	72.66
	8081676	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.09	CHEMBL2543	Homo sapiens	Inhibition	%	0.09
	8081900	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.54	CHEMBL2543	Homo sapiens	Inhibition	%	0.54
	8081928	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	14.22	CHEMBL2543	Homo sapiens	Inhibition	%	14.22
	8082152	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.61	CHEMBL2543	Homo sapiens	Inhibition	%	-2.61
	8082265	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.03	CHEMBL2543	Homo sapiens	Inhibition	%	2.03
	8082662	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.81	CHEMBL2543	Homo sapiens	Inhibition	%	1.81
	8082785	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.72	CHEMBL2543	Homo sapiens	Inhibition	%	1.72
	8083165	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.43	CHEMBL2543	Homo sapiens	Inhibition	%	4.43
	8083488	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.83	CHEMBL2543	Homo sapiens	Inhibition	%	-0.83
	8083742	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.45	CHEMBL2543	Homo sapiens	Inhibition	%	0.45
	8083852	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.68	CHEMBL2543	Homo sapiens	Inhibition	%	1.68
	8084076	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.69	CHEMBL2543	Homo sapiens	Inhibition	%	4.69
	8084261	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.41	CHEMBL2543	Homo sapiens	Inhibition	%	1.41
	8084379	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.95	CHEMBL2543	Homo sapiens	Inhibition	%	2.95
	8084603	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.05	CHEMBL2543	Homo sapiens	Inhibition	%	2.05
	8084764	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.42	CHEMBL2543	Homo sapiens	Inhibition	%	9.42
	8085086	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.91	CHEMBL2543	Homo sapiens	Inhibition	%	0.91
	8085342	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.95	CHEMBL2543	Homo sapiens	Inhibition	%	-2.95
	8085674	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.57	CHEMBL2543	Homo sapiens	Inhibition	%	4.57
	8085863	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	7.05	CHEMBL2543	Homo sapiens	Inhibition	%	7.05
	8086202	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.69	CHEMBL2543	Homo sapiens	Inhibition	%	2.69
	8086364	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.05	CHEMBL2543	Homo sapiens	Inhibition	%	1.05
	8086687	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.24	CHEMBL2543	Homo sapiens	Inhibition	%	0.24
	8086898	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.94	CHEMBL2543	Homo sapiens	Inhibition	%	2.94
	8087122	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	7.62	CHEMBL2543	Homo sapiens	Inhibition	%	7.62
	8087280	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.3	CHEMBL2543	Homo sapiens	Inhibition	%	2.3
	8087618	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.37	CHEMBL2543	Homo sapiens	Inhibition	%	4.37
	8087756	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.06	CHEMBL2543	Homo sapiens	Inhibition	%	4.06
	8088122	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.57	CHEMBL2543	Homo sapiens	Inhibition	%	4.57
	8088270	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.2	CHEMBL2543	Homo sapiens	Inhibition	%	0.2
	8088494	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.9	CHEMBL2543	Homo sapiens	Inhibition	%	0.9
	8088622	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.07	CHEMBL2543	Homo sapiens	Inhibition	%	4.07
	8088939	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.97	CHEMBL2543	Homo sapiens	Inhibition	%	2.97
	8089067	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.58	CHEMBL2543	Homo sapiens	Inhibition	%	-0.58
	8089291	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	6.61	CHEMBL2543	Homo sapiens	Inhibition	%	6.61
	8089439	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.67	CHEMBL2543	Homo sapiens	Inhibition	%	1.67
	8089783	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.2	CHEMBL2543	Homo sapiens	Inhibition	%	0.2
	8089963	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.13	CHEMBL2543	Homo sapiens	Inhibition	%	1.13
	8090352	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.31	CHEMBL2543	Homo sapiens	Inhibition	%	5.31
	8090519	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.09	CHEMBL2543	Homo sapiens	Inhibition	%	2.09
	8090882	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.32	CHEMBL2543	Homo sapiens	Inhibition	%	2.32
	8091087	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.72	CHEMBL2543	Homo sapiens	Inhibition	%	2.72
	8091448	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	31.06	CHEMBL2543	Homo sapiens	Inhibition	%	31.06
	8091603	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.16	CHEMBL2543	Homo sapiens	Inhibition	%	3.16
	8091943	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.85	CHEMBL2543	Homo sapiens	Inhibition	%	3.85
	8092080	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.96	CHEMBL2543	Homo sapiens	Inhibition	%	-1.96
	8092304	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.3	CHEMBL2543	Homo sapiens	Inhibition	%	2.3
	8092455	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.23	CHEMBL2543	Homo sapiens	Inhibition	%	3.23
	8092827	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.42	CHEMBL2543	Homo sapiens	Inhibition	%	0.42
	8092956	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.19	CHEMBL2543	Homo sapiens	Inhibition	%	5.19
	8093268	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.31	CHEMBL2543	Homo sapiens	Inhibition	%	0.31
	8093632	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.05	CHEMBL2543	Homo sapiens	Inhibition	%	-1.05
	8093771	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.64	CHEMBL2543	Homo sapiens	Inhibition	%	0.64
	8094115	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.51	CHEMBL2543	Homo sapiens	Inhibition	%	1.51
	8094295	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.62	CHEMBL2543	Homo sapiens	Inhibition	%	0.62
	8094519	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.08	CHEMBL2543	Homo sapiens	Inhibition	%	1.08
	8094694	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.97	CHEMBL2543	Homo sapiens	Inhibition	%	7.97
	8094850	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.19	CHEMBL2543	Homo sapiens	Inhibition	%	2.19
	8095214	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.66	CHEMBL2543	Homo sapiens	Inhibition	%	2.66
	8095417	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.81	CHEMBL2543	Homo sapiens	Inhibition	%	2.81
	8095782	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%		CHEMBL2543	Homo sapiens	Inhibition	%	
	8095930	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.06	CHEMBL2543	Homo sapiens	Inhibition	%	1.06
	8096154	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.98	CHEMBL2543	Homo sapiens	Inhibition	%	2.98
	8096271	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.6	CHEMBL2543	Homo sapiens	Inhibition	%	4.6
	8096634	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.8	CHEMBL2543	Homo sapiens	Inhibition	%	0.8
	8096790	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.61	CHEMBL2543	Homo sapiens	Inhibition	%	4.61
	8097161	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.26	CHEMBL2543	Homo sapiens	Inhibition	%	0.26
	8097468	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	4.56	CHEMBL2543	Homo sapiens	Inhibition	%	4.56
	8097842	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	2.82	CHEMBL2543	Homo sapiens	Inhibition	%	2.82
	8097975	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.21	CHEMBL2543	Homo sapiens	Inhibition	%	-2.21
	8098199	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.28	CHEMBL2543	Homo sapiens	Inhibition	%	-2.28
	8098319	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.02	CHEMBL2543	Homo sapiens	Inhibition	%	2.02
	8098723	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.03	CHEMBL2543	Homo sapiens	Inhibition	%	1.03
	8098908	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	40.84	CHEMBL2543	Homo sapiens	Inhibition	%	40.84
	8099052	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.63	CHEMBL2543	Homo sapiens	Inhibition	%	1.63
	8099276	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.86	CHEMBL2543	Homo sapiens	Inhibition	%	1.86
	8099418	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.24	CHEMBL2543	Homo sapiens	Inhibition	%	2.24
	8099612	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.0	CHEMBL2543	Homo sapiens	Inhibition	%	2.0
	8099836	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	3.98	CHEMBL2543	Homo sapiens	Inhibition	%	3.98
	8099983	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.88	CHEMBL2543	Homo sapiens	Inhibition	%	6.88
	8100353	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-2.15	CHEMBL2543	Homo sapiens	Inhibition	%	-2.15
	8100469	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	8.41	CHEMBL2543	Homo sapiens	Inhibition	%	8.41
	8100833	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.66	CHEMBL2543	Homo sapiens	Inhibition	%	1.66
	8100993	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.53	CHEMBL2543	Homo sapiens	Inhibition	%	3.53
	8101217	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.82	CHEMBL2543	Homo sapiens	Inhibition	%	3.82
	8101359	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.34	CHEMBL2543	Homo sapiens	Inhibition	%	-1.34
	8101544	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.05	CHEMBL2543	Homo sapiens	Inhibition	%	-0.05
	8101768	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.41	CHEMBL2543	Homo sapiens	Inhibition	%	0.41
	8101797	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.6	CHEMBL2543	Homo sapiens	Inhibition	%	0.6
	8102021	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.26	CHEMBL2543	Homo sapiens	Inhibition	%	4.26
	8102176	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.57	CHEMBL2543	Homo sapiens	Inhibition	%	-1.57
	8102531	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.3	CHEMBL2543	Homo sapiens	Inhibition	%	0.3
	8102651	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.17	CHEMBL2543	Homo sapiens	Inhibition	%	1.17
	8102875	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.29	CHEMBL2543	Homo sapiens	Inhibition	%	0.29
	8103053	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.91	CHEMBL2543	Homo sapiens	Inhibition	%	0.91
	8103249	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.71	CHEMBL2543	Homo sapiens	Inhibition	%	1.71
	8103611	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.97	CHEMBL2543	Homo sapiens	Inhibition	%	0.97
	8103761	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.62	CHEMBL2543	Homo sapiens	Inhibition	%	3.62
	8104170	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.75	CHEMBL2543	Homo sapiens	Inhibition	%	0.75
	8104318	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	11.96	CHEMBL2543	Homo sapiens	Inhibition	%	11.96
	8104688	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.36	CHEMBL2543	Homo sapiens	Inhibition	%	0.36
	8104802	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.52	CHEMBL2543	Homo sapiens	Inhibition	%	3.52
	8105026	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.15	CHEMBL2543	Homo sapiens	Inhibition	%	5.15
	8105166	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.06	CHEMBL2543	Homo sapiens	Inhibition	%	0.06
	8105556	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	0.26	CHEMBL2543	Homo sapiens	Inhibition	%	0.26
	8105694	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.69	CHEMBL2543	Homo sapiens	Inhibition	%	-0.69
	8105974	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.52	CHEMBL2543	Homo sapiens	Inhibition	%	0.52
	8106363	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-3.5	CHEMBL2543	Homo sapiens	Inhibition	%	-3.5
	8106519	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	1.89	CHEMBL2543	Homo sapiens	Inhibition	%	1.89
	8106872	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.29	CHEMBL2543	Homo sapiens	Inhibition	%	-0.29
	8107217	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.8	CHEMBL2543	Homo sapiens	Inhibition	%	1.8
	8107389	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.61	CHEMBL2543	Homo sapiens	Inhibition	%	0.61
	8107590	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.45	CHEMBL2543	Homo sapiens	Inhibition	%	5.45
	8107814	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.92	CHEMBL2543	Homo sapiens	Inhibition	%	1.92
	8107949	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.73	CHEMBL2543	Homo sapiens	Inhibition	%	1.73
	8108107	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.4	CHEMBL2543	Homo sapiens	Inhibition	%	3.4
	8108331	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.65	CHEMBL2543	Homo sapiens	Inhibition	%	3.65
	8108506	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.64	CHEMBL2543	Homo sapiens	Inhibition	%	1.64
	8108653	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.69	CHEMBL2543	Homo sapiens	Inhibition	%	5.69
	8108877	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	7.87	CHEMBL2543	Homo sapiens	Inhibition	%	7.87
	8109019	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.09	CHEMBL2543	Homo sapiens	Inhibition	%	0.09
	8109357	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.11	CHEMBL2543	Homo sapiens	Inhibition	%	4.11
	8109487	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.65	CHEMBL2543	Homo sapiens	Inhibition	%	2.65
	8109711	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.21	CHEMBL2543	Homo sapiens	Inhibition	%	0.21
	8109882	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.19	CHEMBL2543	Homo sapiens	Inhibition	%	-0.19
	8110014	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.11	CHEMBL2543	Homo sapiens	Inhibition	%	4.11
	8110238	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.36	CHEMBL2543	Homo sapiens	Inhibition	%	5.36
	8110293	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.49	CHEMBL2543	Homo sapiens	Inhibition	%	2.49
	8110517	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.35	CHEMBL2543	Homo sapiens	Inhibition	%	0.35
	8110683	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-1.02	CHEMBL2543	Homo sapiens	Inhibition	%	-1.02
	8110841	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.29	CHEMBL2543	Homo sapiens	Inhibition	%	-0.29
	8111065	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.49	CHEMBL2543	Homo sapiens	Inhibition	%	-2.49
	8111188	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.08	CHEMBL2543	Homo sapiens	Inhibition	%	1.08
	8111539	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.05	CHEMBL2543	Homo sapiens	Inhibition	%	1.05
	8111705	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.89	CHEMBL2543	Homo sapiens	Inhibition	%	0.89
	8112134	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.38	CHEMBL2543	Homo sapiens	Inhibition	%	3.38
	8112271	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.14	CHEMBL2543	Homo sapiens	Inhibition	%	0.14
	8112663	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.73	CHEMBL2543	Homo sapiens	Inhibition	%	2.73
	8112835	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.24	CHEMBL2543	Homo sapiens	Inhibition	%	0.24
	8113211	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.26	CHEMBL2543	Homo sapiens	Inhibition	%	3.26
	8113347	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.75	CHEMBL2543	Homo sapiens	Inhibition	%	1.75
	8113695	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	8.38	CHEMBL2543	Homo sapiens	Inhibition	%	8.38
	8114035	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.2	CHEMBL2543	Homo sapiens	Inhibition	%	-0.2
	8114211	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.14	CHEMBL2543	Homo sapiens	Inhibition	%	3.14
	8114567	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.05	CHEMBL2543	Homo sapiens	Inhibition	%	4.05
	8114843	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.68	CHEMBL2543	Homo sapiens	Inhibition	%	2.68
	8115009	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.83	CHEMBL2543	Homo sapiens	Inhibition	%	0.83
	8115398	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.28	CHEMBL2543	Homo sapiens	Inhibition	%	-0.28
	8115518	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.48	CHEMBL2543	Homo sapiens	Inhibition	%	0.48
	8115742	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.92	CHEMBL2543	Homo sapiens	Inhibition	%	1.92
	8115875	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.18	CHEMBL2543	Homo sapiens	Inhibition	%	2.18
	8116034	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.93	CHEMBL2543	Homo sapiens	Inhibition	%	0.93
	8116258	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	3.6	CHEMBL2543	Homo sapiens	Inhibition	%	3.6
	8116461	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.46	CHEMBL2543	Homo sapiens	Inhibition	%	2.46
	8116595	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.28	CHEMBL2543	Homo sapiens	Inhibition	%	0.28
	8116819	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.63	CHEMBL2543	Homo sapiens	Inhibition	%	0.63
	8116991	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.79	CHEMBL2543	Homo sapiens	Inhibition	%	3.79
	8117162	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.93	CHEMBL2543	Homo sapiens	Inhibition	%	0.93
	8117386	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.15	CHEMBL2543	Homo sapiens	Inhibition	%	0.15
	8117544	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	6.19	CHEMBL2543	Homo sapiens	Inhibition	%	6.19
	8117674	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.08	CHEMBL2543	Homo sapiens	Inhibition	%	-0.08
	8117898	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.01	CHEMBL2543	Homo sapiens	Inhibition	%	0.01
	8118036	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.65	CHEMBL2543	Homo sapiens	Inhibition	%	-0.65
	8118376	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.61	CHEMBL2543	Homo sapiens	Inhibition	%	4.61
	8118548	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.89	CHEMBL2543	Homo sapiens	Inhibition	%	3.89
	8118908	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.82	CHEMBL2543	Homo sapiens	Inhibition	%	4.82
	8119179	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.61	CHEMBL2543	Homo sapiens	Inhibition	%	1.61
	8119338	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	4.53	CHEMBL2543	Homo sapiens	Inhibition	%	4.53
	8119562	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.04	CHEMBL2543	Homo sapiens	Inhibition	%	2.04
	8119729	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-2.14	CHEMBL2543	Homo sapiens	Inhibition	%	-2.14
	8120072	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.64	CHEMBL2543	Homo sapiens	Inhibition	%	0.64
	8120211	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.1	CHEMBL2543	Homo sapiens	Inhibition	%	0.1
	8120595	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.61	CHEMBL2543	Homo sapiens	Inhibition	%	-0.61
	8120796	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.98	CHEMBL2543	Homo sapiens	Inhibition	%	3.98
	8121148	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.09	CHEMBL2543	Homo sapiens	Inhibition	%	0.09
	8121320	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.49	CHEMBL2543	Homo sapiens	Inhibition	%	2.49
	8121711	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.54	CHEMBL2543	Homo sapiens	Inhibition	%	0.54
	8121874	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.34	CHEMBL2543	Homo sapiens	Inhibition	%	3.34
	8122219	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-2.39	CHEMBL2543	Homo sapiens	Inhibition	%	-2.39
	8122357	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.91	CHEMBL2543	Homo sapiens	Inhibition	%	1.91
	8122581	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.65	CHEMBL2543	Homo sapiens	Inhibition	%	2.65
	8122701	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.53	CHEMBL2543	Homo sapiens	Inhibition	%	5.53
	8122868	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.64	CHEMBL2543	Homo sapiens	Inhibition	%	3.64
	8123092	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.47	CHEMBL2543	Homo sapiens	Inhibition	%	6.47
	8123234	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.34	CHEMBL2543	Homo sapiens	Inhibition	%	0.34
	8123512	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	20.01	CHEMBL2543	Homo sapiens	Inhibition	%	20.01
	8123886	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	18.13	CHEMBL2543	Homo sapiens	Inhibition	%	18.13
	8124053	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.36	CHEMBL2543	Homo sapiens	Inhibition	%	-3.36
	8124396	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.45	CHEMBL2543	Homo sapiens	Inhibition	%	4.45
	8124535	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.66	CHEMBL2543	Homo sapiens	Inhibition	%	1.66
	8124759	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.4	CHEMBL2543	Homo sapiens	Inhibition	%	1.4
	8124924	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.77	CHEMBL2543	Homo sapiens	Inhibition	%	0.77
	8125125	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.26	CHEMBL2543	Homo sapiens	Inhibition	%	3.26
	8125479	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.76	CHEMBL2543	Homo sapiens	Inhibition	%	-0.76
	8125647	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.93	CHEMBL2543	Homo sapiens	Inhibition	%	2.93
	8125871	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.35	CHEMBL2543	Homo sapiens	Inhibition	%	3.35
	8126035	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.42	CHEMBL2543	Homo sapiens	Inhibition	%	-0.42
	8126199	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.04	CHEMBL2543	Homo sapiens	Inhibition	%	5.04
	8126538	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.27	CHEMBL2543	Homo sapiens	Inhibition	%	-0.27
	8126898	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	11.06	CHEMBL2543	Homo sapiens	Inhibition	%	11.06
	8127020	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.54	CHEMBL2543	Homo sapiens	Inhibition	%	5.54
	8127411	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.91	CHEMBL2543	Homo sapiens	Inhibition	%	3.91
	8127553	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.15	CHEMBL2543	Homo sapiens	Inhibition	%	1.15
	8127777	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.03	CHEMBL2543	Homo sapiens	Inhibition	%	4.03
	8127841	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.59	CHEMBL2543	Homo sapiens	Inhibition	%	0.59
	8128217	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.03	CHEMBL2543	Homo sapiens	Inhibition	%	1.03
	8128384	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-5.36	CHEMBL2543	Homo sapiens	Inhibition	%	-5.36
	8128608	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.91	CHEMBL2543	Homo sapiens	Inhibition	%	0.91
	8128727	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	47.18	CHEMBL2543	Homo sapiens	Inhibition	%	47.18
	8129088	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.13	CHEMBL2543	Homo sapiens	Inhibition	%	1.13
	8129259	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.84	CHEMBL2543	Homo sapiens	Inhibition	%	-0.84
	8129448	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	11.54	CHEMBL2543	Homo sapiens	Inhibition	%	11.54
	8129672	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.94	CHEMBL2543	Homo sapiens	Inhibition	%	1.94
	8129811	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.48	CHEMBL2543	Homo sapiens	Inhibition	%	-0.48
	8130196	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	14.11	CHEMBL2543	Homo sapiens	Inhibition	%	14.11
	8130368	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.17	CHEMBL2543	Homo sapiens	Inhibition	%	-0.17
	8130528	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.79	CHEMBL2543	Homo sapiens	Inhibition	%	1.79
	8130752	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	13.74	CHEMBL2543	Homo sapiens	Inhibition	%	13.74
	8130868	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.58	CHEMBL2543	Homo sapiens	Inhibition	%	3.58
	8131231	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.57	CHEMBL2543	Homo sapiens	Inhibition	%	3.57
	8131351	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	14.55	CHEMBL2543	Homo sapiens	Inhibition	%	14.55
	8131575	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.69	CHEMBL2543	Homo sapiens	Inhibition	%	0.69
	8131742	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.64	CHEMBL2543	Homo sapiens	Inhibition	%	4.64
	8132107	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	7.31	CHEMBL2543	Homo sapiens	Inhibition	%	7.31
	8132169	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.44	CHEMBL2543	Homo sapiens	Inhibition	%	3.44
	8132393	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.38	CHEMBL2543	Homo sapiens	Inhibition	%	-2.38
	8132540	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.24	CHEMBL2543	Homo sapiens	Inhibition	%	3.24
	8132932	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.77	CHEMBL2543	Homo sapiens	Inhibition	%	-0.77
	8133053	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.44	CHEMBL2543	Homo sapiens	Inhibition	%	1.44
	8133415	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-0.21	CHEMBL2543	Homo sapiens	Inhibition	%	-0.21
	8133587	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.77	CHEMBL2543	Homo sapiens	Inhibition	%	-0.77
	8133991	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.64	CHEMBL2543	Homo sapiens	Inhibition	%	1.64
	8134139	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.59	CHEMBL2543	Homo sapiens	Inhibition	%	-0.59
	8134523	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.62	CHEMBL2543	Homo sapiens	Inhibition	%	2.62
	8134707	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-1.68	CHEMBL2543	Homo sapiens	Inhibition	%	-1.68
	8135091	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.75	CHEMBL2543	Homo sapiens	Inhibition	%	2.75
	8135206	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.83	CHEMBL2543	Homo sapiens	Inhibition	%	4.83
	8135430	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.82	CHEMBL2543	Homo sapiens	Inhibition	%	3.82
	8135571	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.18	CHEMBL2543	Homo sapiens	Inhibition	%	7.18
	8135916	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.77	CHEMBL2543	Homo sapiens	Inhibition	%	2.77
	8136084	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.16	CHEMBL2543	Homo sapiens	Inhibition	%	3.16
	8136452	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.86	CHEMBL2543	Homo sapiens	Inhibition	%	4.86
	8136742	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	10.39	CHEMBL2543	Homo sapiens	Inhibition	%	10.39
	8136877	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.32	CHEMBL2543	Homo sapiens	Inhibition	%	0.32
	8137264	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.79	CHEMBL2543	Homo sapiens	Inhibition	%	1.79
	8137384	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	12.02	CHEMBL2543	Homo sapiens	Inhibition	%	12.02
	8137608	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.38	CHEMBL2543	Homo sapiens	Inhibition	%	-2.38
	8137756	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-0.19	CHEMBL2543	Homo sapiens	Inhibition	%	-0.19
	8137922	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.34	CHEMBL2543	Homo sapiens	Inhibition	%	-1.34
	8138146	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.07	CHEMBL2543	Homo sapiens	Inhibition	%	-1.07
	8138325	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.96	CHEMBL2543	Homo sapiens	Inhibition	%	0.96
	8138473	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.54	CHEMBL2543	Homo sapiens	Inhibition	%	-0.54
	8138697	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.65	CHEMBL2543	Homo sapiens	Inhibition	%	-2.65
	8138855	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.57	CHEMBL2543	Homo sapiens	Inhibition	%	3.57
	8139040	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	2.22	CHEMBL2543	Homo sapiens	Inhibition	%	2.22
	8139264	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.7	CHEMBL2543	Homo sapiens	Inhibition	%	3.7
	8139423	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	6.46	CHEMBL2543	Homo sapiens	Inhibition	%	6.46
	8139761	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.2	CHEMBL2543	Homo sapiens	Inhibition	%	4.2
	8139902	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.65	CHEMBL2543	Homo sapiens	Inhibition	%	3.65
	8140249	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.39	CHEMBL2543	Homo sapiens	Inhibition	%	4.39
	8140408	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.85	CHEMBL2543	Homo sapiens	Inhibition	%	3.85
	8140632	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.4	CHEMBL2543	Homo sapiens	Inhibition	%	2.4
	8140775	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	9.12	CHEMBL2543	Homo sapiens	Inhibition	%	9.12
	8141077	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.72	CHEMBL2543	Homo sapiens	Inhibition	%	0.72
	8141207	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.4	CHEMBL2543	Homo sapiens	Inhibition	%	1.4
	8141431	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.26	CHEMBL2543	Homo sapiens	Inhibition	%	-0.26
	8141591	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.01	CHEMBL2543	Homo sapiens	Inhibition	%	1.01
	8141934	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.99	CHEMBL2543	Homo sapiens	Inhibition	%	-0.99
	8142095	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.93	CHEMBL2543	Homo sapiens	Inhibition	%	1.93
	8142487	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.74	CHEMBL2543	Homo sapiens	Inhibition	%	-1.74
	8142663	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.13	CHEMBL2543	Homo sapiens	Inhibition	%	1.13
	8143036	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.47	CHEMBL2543	Homo sapiens	Inhibition	%	-3.47
	8143191	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.58	CHEMBL2543	Homo sapiens	Inhibition	%	1.58
	8143602	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	6.34	CHEMBL2543	Homo sapiens	Inhibition	%	6.34
	8143761	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.82	CHEMBL2543	Homo sapiens	Inhibition	%	3.82
	8144099	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.49	CHEMBL2543	Homo sapiens	Inhibition	%	-0.49
	8144238	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.36	CHEMBL2543	Homo sapiens	Inhibition	%	5.36
	8144462	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.62	CHEMBL2543	Homo sapiens	Inhibition	%	4.62
	8144592	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	6.06	CHEMBL2543	Homo sapiens	Inhibition	%	6.06
	8144969	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.38	CHEMBL2543	Homo sapiens	Inhibition	%	2.38
	8145106	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.49	CHEMBL2543	Homo sapiens	Inhibition	%	4.49
	8145419	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.57	CHEMBL2543	Homo sapiens	Inhibition	%	2.57
	8145767	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.22	CHEMBL2543	Homo sapiens	Inhibition	%	1.22
	8145928	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.06	CHEMBL2543	Homo sapiens	Inhibition	%	1.06
	8146272	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.85	CHEMBL2543	Homo sapiens	Inhibition	%	-0.85
	8146432	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	3.08	CHEMBL2543	Homo sapiens	Inhibition	%	3.08
	8146656	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2	Outside typical range	CHEMBL456252	=	Inhibition	%	-12.28	CHEMBL2543	Homo sapiens	Inhibition	%	-12.28
	8146823	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-3.37	CHEMBL2543	Homo sapiens	Inhibition	%	-3.37
	8146992	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.85	CHEMBL2543	Homo sapiens	Inhibition	%	1.85
	8147216	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.66	CHEMBL2543	Homo sapiens	Inhibition	%	1.66
	8147358	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.27	CHEMBL2543	Homo sapiens	Inhibition	%	2.27
	8147511	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.65	CHEMBL2543	Homo sapiens	Inhibition	%	2.65
	8147735	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.72	CHEMBL2543	Homo sapiens	Inhibition	%	2.72
	8147922	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.6	CHEMBL2543	Homo sapiens	Inhibition	%	4.6
	8148080	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	12.02	CHEMBL2543	Homo sapiens	Inhibition	%	12.02
	8148304	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.32	CHEMBL2543	Homo sapiens	Inhibition	%	3.32
	8148418	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.24	CHEMBL2543	Homo sapiens	Inhibition	%	-0.24
	8148781	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	20.3	CHEMBL2543	Homo sapiens	Inhibition	%	20.3
	8148919	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.16	CHEMBL2543	Homo sapiens	Inhibition	%	5.16
	8149143	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	7.07	CHEMBL2543	Homo sapiens	Inhibition	%	7.07
	8149302	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.98	CHEMBL2543	Homo sapiens	Inhibition	%	-1.98
	8149436	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.75	CHEMBL2543	Homo sapiens	Inhibition	%	5.75
	8149660	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.81	CHEMBL2543	Homo sapiens	Inhibition	%	3.81
	8149758	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.3	CHEMBL2543	Homo sapiens	Inhibition	%	0.3
	8149982	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.73	CHEMBL2543	Homo sapiens	Inhibition	%	2.73
	8150107	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-4.05	CHEMBL2543	Homo sapiens	Inhibition	%	-4.05
	8150267	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.63	CHEMBL2543	Homo sapiens	Inhibition	%	0.63
	8150491	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.23	CHEMBL2543	Homo sapiens	Inhibition	%	1.23
	8150611	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.01	CHEMBL2543	Homo sapiens	Inhibition	%	1.01
	8151000	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-7.97	CHEMBL2543	Homo sapiens	Inhibition	%	-7.97
	8151163	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.87	CHEMBL2543	Homo sapiens	Inhibition	%	-2.87
	8151564	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.32	CHEMBL2543	Homo sapiens	Inhibition	%	1.32
	8151702	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.62	CHEMBL2543	Homo sapiens	Inhibition	%	2.62
	8152080	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.2	CHEMBL2543	Homo sapiens	Inhibition	%	2.2
	8152268	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.12	CHEMBL2543	Homo sapiens	Inhibition	%	6.12
	8152650	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.31	CHEMBL2543	Homo sapiens	Inhibition	%	5.31
	8152764	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.88	CHEMBL2543	Homo sapiens	Inhibition	%	3.88
	8152988	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.44	CHEMBL2543	Homo sapiens	Inhibition	%	4.44
	8153127	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.31	CHEMBL2543	Homo sapiens	Inhibition	%	2.31
	8153488	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.43	CHEMBL2543	Homo sapiens	Inhibition	%	4.43
	8153645	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.18	CHEMBL2543	Homo sapiens	Inhibition	%	-2.18
	8154002	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.17	CHEMBL2543	Homo sapiens	Inhibition	%	5.17
	8154323	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.92	CHEMBL2543	Homo sapiens	Inhibition	%	0.92
	8154449	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-2.38	CHEMBL2543	Homo sapiens	Inhibition	%	-2.38
	8154832	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.26	CHEMBL2543	Homo sapiens	Inhibition	%	1.26
	8154952	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.48	CHEMBL2543	Homo sapiens	Inhibition	%	0.48
	8155176	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.57	CHEMBL2543	Homo sapiens	Inhibition	%	2.57
	8155352	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.3	CHEMBL2543	Homo sapiens	Inhibition	%	0.3
	8155513	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.39	CHEMBL2543	Homo sapiens	Inhibition	%	-3.39
	8155737	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.46	CHEMBL2543	Homo sapiens	Inhibition	%	2.46
	8155915	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.18	CHEMBL2543	Homo sapiens	Inhibition	%	2.18
	8156053	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.06	CHEMBL2543	Homo sapiens	Inhibition	%	2.06
	8156277	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.07	CHEMBL2543	Homo sapiens	Inhibition	%	3.07
	8156489	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.32	CHEMBL2543	Homo sapiens	Inhibition	%	2.32
	8156639	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.92	CHEMBL2543	Homo sapiens	Inhibition	%	1.92
	8157006	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.34	CHEMBL2543	Homo sapiens	Inhibition	%	4.34
	8157350	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.14	CHEMBL2543	Homo sapiens	Inhibition	%	3.14
	8157491	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.07	CHEMBL2543	Homo sapiens	Inhibition	%	2.07
	8157845	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.29	CHEMBL2543	Homo sapiens	Inhibition	%	2.29
	8158006	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.05	CHEMBL2543	Homo sapiens	Inhibition	%	0.05
	8158256	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.03	CHEMBL2543	Homo sapiens	Inhibition	%	4.03
	8158480	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.12	CHEMBL2543	Homo sapiens	Inhibition	%	3.12
	8158638	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.39	CHEMBL2543	Homo sapiens	Inhibition	%	2.39
	8158807	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.53	CHEMBL2543	Homo sapiens	Inhibition	%	2.53
	8159031	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.38	CHEMBL2543	Homo sapiens	Inhibition	%	3.38
	8159166	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.99	CHEMBL2543	Homo sapiens	Inhibition	%	4.99
	8159510	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.41	CHEMBL2543	Homo sapiens	Inhibition	%	-1.41
	8159641	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.96	CHEMBL2543	Homo sapiens	Inhibition	%	5.96
	8159865	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	29.6	CHEMBL2543	Homo sapiens	Inhibition	%	29.6
	8160006	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.81	CHEMBL2543	Homo sapiens	Inhibition	%	1.81
	8160143	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.2	CHEMBL2543	Homo sapiens	Inhibition	%	3.2
	8160367	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.04	CHEMBL2543	Homo sapiens	Inhibition	%	6.04
	8160517	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.13	CHEMBL2543	Homo sapiens	Inhibition	%	-1.13
	8160811	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.03	CHEMBL2543	Homo sapiens	Inhibition	%	5.03
	8160961	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.34	CHEMBL2543	Homo sapiens	Inhibition	%	3.34
	8161185	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.47	CHEMBL2543	Homo sapiens	Inhibition	%	1.47
	8161328	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.95	CHEMBL2543	Homo sapiens	Inhibition	%	7.95
	8161677	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.14	CHEMBL2543	Homo sapiens	Inhibition	%	1.14
	8161815	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.91	CHEMBL2543	Homo sapiens	Inhibition	%	3.91
	8162039	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.72	CHEMBL2543	Homo sapiens	Inhibition	%	1.72
	8162169	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.19	CHEMBL2543	Homo sapiens	Inhibition	%	2.19
	8162329	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-4.72	CHEMBL2543	Homo sapiens	Inhibition	%	-4.72
	8162553	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-2.41	CHEMBL2543	Homo sapiens	Inhibition	%	-2.41
	8162806	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.73	CHEMBL2543	Homo sapiens	Inhibition	%	3.73
	8162954	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	3.58	CHEMBL2543	Homo sapiens	Inhibition	%	3.58
	8163347	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.2	CHEMBL2543	Homo sapiens	Inhibition	%	2.2
	8163481	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.59	CHEMBL2543	Homo sapiens	Inhibition	%	5.59
	8163828	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.73	CHEMBL2543	Homo sapiens	Inhibition	%	-0.73
	8164186	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	78.63	CHEMBL2543	Homo sapiens	Inhibition	%	78.63
	8164326	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.35	CHEMBL2543	Homo sapiens	Inhibition	%	0.35
	8164705	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	6.38	CHEMBL2543	Homo sapiens	Inhibition	%	6.38
	8164849	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	3.41	CHEMBL2543	Homo sapiens	Inhibition	%	3.41
	8165143	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.28	CHEMBL2543	Homo sapiens	Inhibition	%	2.28
	8165508	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.49	CHEMBL2543	Homo sapiens	Inhibition	%	3.49
	8165651	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	46.85	CHEMBL2543	Homo sapiens	Inhibition	%	46.85
	8166001	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.79	CHEMBL2543	Homo sapiens	Inhibition	%	2.79
	8166363	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.87	CHEMBL2543	Homo sapiens	Inhibition	%	4.87
	8166493	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.14	CHEMBL2543	Homo sapiens	Inhibition	%	2.14
	8166818	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	9.2	CHEMBL2543	Homo sapiens	Inhibition	%	9.2
	8167130	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.55	CHEMBL2543	Homo sapiens	Inhibition	%	2.55
	8167271	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	19.46	CHEMBL2543	Homo sapiens	Inhibition	%	19.46
	8167495	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	3.76	CHEMBL2543	Homo sapiens	Inhibition	%	3.76
	8167659	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.02	CHEMBL2543	Homo sapiens	Inhibition	%	3.02
	8167792	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.17	CHEMBL2543	Homo sapiens	Inhibition	%	5.17
	8168016	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.68	CHEMBL2543	Homo sapiens	Inhibition	%	5.68
	8168140	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.41	CHEMBL2543	Homo sapiens	Inhibition	%	1.41
	8168505	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.87	CHEMBL2543	Homo sapiens	Inhibition	%	5.87
	8168641	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.56	CHEMBL2543	Homo sapiens	Inhibition	%	0.56
	8168865	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.75	CHEMBL2543	Homo sapiens	Inhibition	%	-0.75
	8169029	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	41.38	CHEMBL2543	Homo sapiens	Inhibition	%	41.38
	8169171	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.91	CHEMBL2543	Homo sapiens	Inhibition	%	1.91
	8169395	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.11	CHEMBL2543	Homo sapiens	Inhibition	%	4.11
	8169475	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.64	CHEMBL2543	Homo sapiens	Inhibition	%	5.64
	8169699	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.01	CHEMBL2543	Homo sapiens	Inhibition	%	3.01
	8169833	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.59	CHEMBL2543	Homo sapiens	Inhibition	%	3.59
	8169978	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.5	CHEMBL2543	Homo sapiens	Inhibition	%	0.5
	8170202	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.8	CHEMBL2543	Homo sapiens	Inhibition	%	1.8
	8170327	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.59	CHEMBL2543	Homo sapiens	Inhibition	%	1.59
	8170691	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.19	CHEMBL2543	Homo sapiens	Inhibition	%	-1.19
	8170826	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.78	CHEMBL2543	Homo sapiens	Inhibition	%	2.78
	8171050	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.16	CHEMBL2543	Homo sapiens	Inhibition	%	3.16
	8171247	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-0.28	CHEMBL2543	Homo sapiens	Inhibition	%	-0.28
	8171464	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.09	CHEMBL2543	Homo sapiens	Inhibition	%	3.09
	8171829	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	20.56	CHEMBL2543	Homo sapiens	Inhibition	%	20.56
	8171982	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.9	CHEMBL2543	Homo sapiens	Inhibition	%	-1.9
	8172338	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.6	CHEMBL2543	Homo sapiens	Inhibition	%	3.6
	8172466	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.77	CHEMBL2543	Homo sapiens	Inhibition	%	1.77
	8172690	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.83	CHEMBL2543	Homo sapiens	Inhibition	%	0.83
	8172832	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	19.92	CHEMBL2543	Homo sapiens	Inhibition	%	19.92
	8173192	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.38	CHEMBL2543	Homo sapiens	Inhibition	%	-1.38
	8173357	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.26	CHEMBL2543	Homo sapiens	Inhibition	%	3.26
	8173722	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.62	CHEMBL2543	Homo sapiens	Inhibition	%	2.62
	8174033	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	9.23	CHEMBL2543	Homo sapiens	Inhibition	%	9.23
	8174165	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.68	CHEMBL2543	Homo sapiens	Inhibition	%	2.68
	8174537	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.59	CHEMBL2543	Homo sapiens	Inhibition	%	1.59
	8174659	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.46	CHEMBL2543	Homo sapiens	Inhibition	%	2.46
	8174883	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.8	CHEMBL2543	Homo sapiens	Inhibition	%	1.8
	8175026	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	0.7	CHEMBL2543	Homo sapiens	Inhibition	%	0.7
	8175386	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	24.88	CHEMBL2543	Homo sapiens	Inhibition	%	24.88
	8175642	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	8.25	CHEMBL2543	Homo sapiens	Inhibition	%	8.25
	8175805	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.72	CHEMBL2543	Homo sapiens	Inhibition	%	1.72
	8176182	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.49	CHEMBL2543	Homo sapiens	Inhibition	%	3.49
	8176331	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.18	CHEMBL2543	Homo sapiens	Inhibition	%	-0.18
	8176555	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.13	CHEMBL2543	Homo sapiens	Inhibition	%	1.13
	8176687	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	7.61	CHEMBL2543	Homo sapiens	Inhibition	%	7.61
	8177041	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.02	CHEMBL2543	Homo sapiens	Inhibition	%	4.02
	8177183	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	0.59	CHEMBL2543	Homo sapiens	Inhibition	%	0.59
	8177545	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.32	CHEMBL2543	Homo sapiens	Inhibition	%	2.32
	8177709	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	9.79	CHEMBL2543	Homo sapiens	Inhibition	%	9.79
	8177933	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.47	CHEMBL2543	Homo sapiens	Inhibition	%	3.47
	8178073	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.44	CHEMBL2543	Homo sapiens	Inhibition	%	4.44
	8178385	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.17	CHEMBL2543	Homo sapiens	Inhibition	%	2.17
	8178512	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.31	CHEMBL2543	Homo sapiens	Inhibition	%	3.31
	8178736	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.98	CHEMBL2543	Homo sapiens	Inhibition	%	3.98
	8178885	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.47	CHEMBL2543	Homo sapiens	Inhibition	%	2.47
	8179232	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.86	CHEMBL2543	Homo sapiens	Inhibition	%	2.86
	8179376	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.94	CHEMBL2543	Homo sapiens	Inhibition	%	1.94
	8179737	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.76	CHEMBL2543	Homo sapiens	Inhibition	%	0.76
	8179994	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.51	CHEMBL2543	Homo sapiens	Inhibition	%	3.51
	8180148	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.93	CHEMBL2543	Homo sapiens	Inhibition	%	2.93
	8180372	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.97	CHEMBL2543	Homo sapiens	Inhibition	%	-1.97
	8180528	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.87	CHEMBL2543	Homo sapiens	Inhibition	%	7.87
	8180900	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.27	CHEMBL2543	Homo sapiens	Inhibition	%	1.27
	8181033	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.13	CHEMBL2543	Homo sapiens	Inhibition	%	4.13
	8181388	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.03	CHEMBL2543	Homo sapiens	Inhibition	%	1.03
	8181528	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.73	CHEMBL2543	Homo sapiens	Inhibition	%	3.73
	8181752	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.46	CHEMBL2543	Homo sapiens	Inhibition	%	4.46
	8181891	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.1	CHEMBL2543	Homo sapiens	Inhibition	%	3.1
	8182278	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	8.8	CHEMBL2543	Homo sapiens	Inhibition	%	8.8
	8182418	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.53	CHEMBL2543	Homo sapiens	Inhibition	%	1.53
	8182734	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.66	CHEMBL2543	Homo sapiens	Inhibition	%	1.66
	8183080	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.65	CHEMBL2543	Homo sapiens	Inhibition	%	4.65
	8183229	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.91	CHEMBL2543	Homo sapiens	Inhibition	%	1.91
	8183582	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.52	CHEMBL2543	Homo sapiens	Inhibition	%	0.52
	8183724	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.22	CHEMBL2543	Homo sapiens	Inhibition	%	4.22
	8183948	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.56	CHEMBL2543	Homo sapiens	Inhibition	%	2.56
	8184084	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.18	CHEMBL2543	Homo sapiens	Inhibition	%	3.18
	8184350	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.16	CHEMBL2543	Homo sapiens	Inhibition	%	6.16
	8184721	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.46	CHEMBL2543	Homo sapiens	Inhibition	%	-1.46
	8184878	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	11.08	CHEMBL2543	Homo sapiens	Inhibition	%	11.08
	8185251	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.69	CHEMBL2543	Homo sapiens	Inhibition	%	-0.69
	8185382	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	6.1	CHEMBL2543	Homo sapiens	Inhibition	%	6.1
	8185606	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.57	CHEMBL2543	Homo sapiens	Inhibition	%	0.57
	8185737	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	18.68	CHEMBL2543	Homo sapiens	Inhibition	%	18.68
	8186100	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.84	CHEMBL2543	Homo sapiens	Inhibition	%	4.84
	8186241	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.31	CHEMBL2543	Homo sapiens	Inhibition	%	3.31
	8186629	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.12	CHEMBL2543	Homo sapiens	Inhibition	%	3.12
	8186768	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.13	CHEMBL2543	Homo sapiens	Inhibition	%	4.13
	8186992	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.73	CHEMBL2543	Homo sapiens	Inhibition	%	4.73
	8187090	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.83	CHEMBL2543	Homo sapiens	Inhibition	%	1.83
	8187438	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.21	CHEMBL2543	Homo sapiens	Inhibition	%	3.21
	8187586	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.73	CHEMBL2543	Homo sapiens	Inhibition	%	3.73
	8187810	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.49	CHEMBL2543	Homo sapiens	Inhibition	%	1.49
	8187939	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.81	CHEMBL2543	Homo sapiens	Inhibition	%	0.81
	8188306	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.33	CHEMBL2543	Homo sapiens	Inhibition	%	3.33
	8188441	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.87	CHEMBL2543	Homo sapiens	Inhibition	%	-2.87
	8188665	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.73	CHEMBL2543	Homo sapiens	Inhibition	%	-0.73
	8188715	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.69	CHEMBL2543	Homo sapiens	Inhibition	%	3.69
	8188939	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.69	CHEMBL2543	Homo sapiens	Inhibition	%	5.69
	8189087	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.49	CHEMBL2543	Homo sapiens	Inhibition	%	1.49
	8189243	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	61.65	CHEMBL2543	Homo sapiens	Inhibition	%	61.65
	8189467	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.71	CHEMBL2543	Homo sapiens	Inhibition	%	3.71
	8189616	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.99	CHEMBL2543	Homo sapiens	Inhibition	%	0.99
	8189972	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.61	CHEMBL2543	Homo sapiens	Inhibition	%	1.61
	8190104	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.14	CHEMBL2543	Homo sapiens	Inhibition	%	3.14
	8190328	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.34	CHEMBL2543	Homo sapiens	Inhibition	%	6.34
	8190468	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.86	CHEMBL2543	Homo sapiens	Inhibition	%	3.86
	8190605	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.56	CHEMBL2543	Homo sapiens	Inhibition	%	3.56
	8190829	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.94	CHEMBL2543	Homo sapiens	Inhibition	%	2.94
	8190993	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.63	CHEMBL2543	Homo sapiens	Inhibition	%	4.63
	8191355	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.71	CHEMBL2543	Homo sapiens	Inhibition	%	4.71
	8191451	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.37	CHEMBL2543	Homo sapiens	Inhibition	%	2.37
	8191675	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.59	CHEMBL2543	Homo sapiens	Inhibition	%	0.59
	8191797	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.44	CHEMBL2543	Homo sapiens	Inhibition	%	7.44
	8192170	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.11	CHEMBL2543	Homo sapiens	Inhibition	%	5.11
	8192299	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.05	CHEMBL2543	Homo sapiens	Inhibition	%	1.05
	8192523	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.62	CHEMBL2543	Homo sapiens	Inhibition	%	0.62
	8192667	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.46	CHEMBL2543	Homo sapiens	Inhibition	%	2.46
	8193027	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.22	CHEMBL2543	Homo sapiens	Inhibition	%	-0.22
	8193299	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.82	CHEMBL2543	Homo sapiens	Inhibition	%	3.82
	8193444	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.8	CHEMBL2543	Homo sapiens	Inhibition	%	0.8
	8193825	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	12.72	CHEMBL2543	Homo sapiens	Inhibition	%	12.72
	8193974	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.88	CHEMBL2543	Homo sapiens	Inhibition	%	-0.88
	8194329	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.2	CHEMBL2543	Homo sapiens	Inhibition	%	4.2
	8194684	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.83	CHEMBL2543	Homo sapiens	Inhibition	%	2.83
	8194827	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.95	CHEMBL2543	Homo sapiens	Inhibition	%	4.95
	8195184	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.84	CHEMBL2543	Homo sapiens	Inhibition	%	5.84
	8195348	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.66	CHEMBL2543	Homo sapiens	Inhibition	%	1.66
	8195711	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.01	CHEMBL2543	Homo sapiens	Inhibition	%	3.01
	8196033	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.44	CHEMBL2543	Homo sapiens	Inhibition	%	2.44
	8196150	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.94	CHEMBL2543	Homo sapiens	Inhibition	%	2.94
	8196374	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	8.66	CHEMBL2543	Homo sapiens	Inhibition	%	8.66
	8196524	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	5.54	CHEMBL2543	Homo sapiens	Inhibition	%	5.54
	8196876	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-1.54	CHEMBL2543	Homo sapiens	Inhibition	%	-1.54
	8197017	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.72	CHEMBL2543	Homo sapiens	Inhibition	%	2.72
	8197378	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.72	CHEMBL2543	Homo sapiens	Inhibition	%	2.72
	8197653	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	6.08	CHEMBL2543	Homo sapiens	Inhibition	%	6.08
	8197793	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.04	CHEMBL2543	Homo sapiens	Inhibition	%	-0.04
	8198017	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.68	CHEMBL2543	Homo sapiens	Inhibition	%	1.68
	8198174	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.13	CHEMBL2543	Homo sapiens	Inhibition	%	-1.13
	8198312	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.7	CHEMBL2543	Homo sapiens	Inhibition	%	-0.7
	8198536	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.03	CHEMBL2543	Homo sapiens	Inhibition	%	4.03
	8198666	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.75	CHEMBL2543	Homo sapiens	Inhibition	%	4.75
	8199021	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.08	CHEMBL2543	Homo sapiens	Inhibition	%	5.08
	8199169	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.69	CHEMBL2543	Homo sapiens	Inhibition	%	3.69
	8199393	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.2	CHEMBL2543	Homo sapiens	Inhibition	%	5.2
	8199527	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.09	CHEMBL2543	Homo sapiens	Inhibition	%	3.09
	8199690	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	5.46	CHEMBL2543	Homo sapiens	Inhibition	%	5.46
	8199914	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.74	CHEMBL2543	Homo sapiens	Inhibition	%	1.74
	8200052	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.06	CHEMBL2543	Homo sapiens	Inhibition	%	4.06
	8200380	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.23	CHEMBL2543	Homo sapiens	Inhibition	%	0.23
	8200719	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.88	CHEMBL2543	Homo sapiens	Inhibition	%	4.88
	8200869	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	36.63	CHEMBL2543	Homo sapiens	Inhibition	%	36.63
	8201223	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-1.86	CHEMBL2543	Homo sapiens	Inhibition	%	-1.86
	8201358	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.61	CHEMBL2543	Homo sapiens	Inhibition	%	1.61
	8201582	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.43	CHEMBL2543	Homo sapiens	Inhibition	%	3.43
	8201715	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.73	CHEMBL2543	Homo sapiens	Inhibition	%	-0.73
	8201994	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.69	CHEMBL2543	Homo sapiens	Inhibition	%	2.69
	8202358	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.3	CHEMBL2543	Homo sapiens	Inhibition	%	-1.3
	8202525	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.78	CHEMBL2543	Homo sapiens	Inhibition	%	4.78
	8202874	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.19	CHEMBL2543	Homo sapiens	Inhibition	%	6.19
	8203004	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.11	CHEMBL2543	Homo sapiens	Inhibition	%	4.11
	8203228	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	13.45	CHEMBL2543	Homo sapiens	Inhibition	%	13.45
	8203359	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.37	CHEMBL2543	Homo sapiens	Inhibition	%	-0.37
	8203729	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.07	CHEMBL2543	Homo sapiens	Inhibition	%	3.07
	8203863	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.69	CHEMBL2543	Homo sapiens	Inhibition	%	4.69
	8204253	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.13	CHEMBL2543	Homo sapiens	Inhibition	%	3.13
	8204390	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.73	CHEMBL2543	Homo sapiens	Inhibition	%	2.73
	8204614	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.53	CHEMBL2543	Homo sapiens	Inhibition	%	6.53
	8204719	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.83	CHEMBL2543	Homo sapiens	Inhibition	%	1.83
	8205058	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	25.1	CHEMBL2543	Homo sapiens	Inhibition	%	25.1
	8205207	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.35	CHEMBL2543	Homo sapiens	Inhibition	%	3.35
	8205431	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	10.38	CHEMBL2543	Homo sapiens	Inhibition	%	10.38
	8205567	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.95	CHEMBL2543	Homo sapiens	Inhibition	%	1.95
	8205930	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.95	CHEMBL2543	Homo sapiens	Inhibition	%	2.95
	8206062	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.3	CHEMBL2543	Homo sapiens	Inhibition	%	-0.3
	8206338	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.77	CHEMBL2543	Homo sapiens	Inhibition	%	3.77
	8206705	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.74	CHEMBL2543	Homo sapiens	Inhibition	%	-0.74
	8206885	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.15	CHEMBL2543	Homo sapiens	Inhibition	%	3.15
	8207235	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.46	CHEMBL2543	Homo sapiens	Inhibition	%	4.46
	8207589	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	4.14	CHEMBL2543	Homo sapiens	Inhibition	%	4.14
	8207721	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.79	CHEMBL2543	Homo sapiens	Inhibition	%	0.79
	8208090	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.14	CHEMBL2543	Homo sapiens	Inhibition	%	5.14
	8208222	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.51	CHEMBL2543	Homo sapiens	Inhibition	%	3.51
	8208446	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.19	CHEMBL2543	Homo sapiens	Inhibition	%	5.19
	8208612	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.16	CHEMBL2543	Homo sapiens	Inhibition	%	1.16
	8208969	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.76	CHEMBL2543	Homo sapiens	Inhibition	%	1.76
	8209074	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.86	CHEMBL2543	Homo sapiens	Inhibition	%	-0.86
	8209298	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.35	CHEMBL2543	Homo sapiens	Inhibition	%	-0.35
	8209414	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.14	CHEMBL2543	Homo sapiens	Inhibition	%	3.14
	8209788	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.0	CHEMBL2543	Homo sapiens	Inhibition	%	1.0
	8209924	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.13	CHEMBL2543	Homo sapiens	Inhibition	%	1.13
	8210289	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.91	CHEMBL2543	Homo sapiens	Inhibition	%	2.91
	8210425	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.74	CHEMBL2543	Homo sapiens	Inhibition	%	-1.74
	8210649	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.99	CHEMBL2543	Homo sapiens	Inhibition	%	-0.99
	8210684	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.05	CHEMBL2543	Homo sapiens	Inhibition	%	-1.05
	8210908	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.06	CHEMBL2543	Homo sapiens	Inhibition	%	1.06
	8211052	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.8	CHEMBL2543	Homo sapiens	Inhibition	%	2.8
	8211222	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.54	CHEMBL2543	Homo sapiens	Inhibition	%	4.54
	8211446	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.09	CHEMBL2543	Homo sapiens	Inhibition	%	3.09
	8211569	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	13.72	CHEMBL2543	Homo sapiens	Inhibition	%	13.72
	8211922	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.38	CHEMBL2543	Homo sapiens	Inhibition	%	7.38
	8212054	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.06	CHEMBL2543	Homo sapiens	Inhibition	%	3.06
	8212278	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.41	CHEMBL2543	Homo sapiens	Inhibition	%	4.41
	8212419	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.45	CHEMBL2543	Homo sapiens	Inhibition	%	2.45
	8212776	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.71	CHEMBL2543	Homo sapiens	Inhibition	%	2.71
	8212946	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.9	CHEMBL2543	Homo sapiens	Inhibition	%	1.9
	8213299	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.78	CHEMBL2543	Homo sapiens	Inhibition	%	3.78
	8213627	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.56	CHEMBL2543	Homo sapiens	Inhibition	%	-1.56
	8213740	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	10.1	CHEMBL2543	Homo sapiens	Inhibition	%	10.1
	8214111	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.7	CHEMBL2543	Homo sapiens	Inhibition	%	1.7
	8214248	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.55	CHEMBL2543	Homo sapiens	Inhibition	%	2.55
	8214472	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.68	CHEMBL2543	Homo sapiens	Inhibition	%	2.68
	8214606	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-1.06	CHEMBL2543	Homo sapiens	Inhibition	%	-1.06
	8214982	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-2.46	CHEMBL2543	Homo sapiens	Inhibition	%	-2.46
	8215233	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.84	CHEMBL2543	Homo sapiens	Inhibition	%	2.84
	8215386	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.73	CHEMBL2543	Homo sapiens	Inhibition	%	4.73
	8215774	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.86	CHEMBL2543	Homo sapiens	Inhibition	%	5.86
	8215893	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.13	CHEMBL2543	Homo sapiens	Inhibition	%	2.13
	8216117	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	15.63	CHEMBL2543	Homo sapiens	Inhibition	%	15.63
	8216236	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.03	CHEMBL2543	Homo sapiens	Inhibition	%	3.03
	8216596	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.27	CHEMBL2543	Homo sapiens	Inhibition	%	3.27
	8216734	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.16	CHEMBL2543	Homo sapiens	Inhibition	%	3.16
	8217092	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.15	CHEMBL2543	Homo sapiens	Inhibition	%	4.15
	8217266	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.49	CHEMBL2543	Homo sapiens	Inhibition	%	0.49
	8217490	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.07	CHEMBL2543	Homo sapiens	Inhibition	%	2.07
	8217621	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.02	CHEMBL2543	Homo sapiens	Inhibition	%	2.02
	8217946	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.57	CHEMBL2543	Homo sapiens	Inhibition	%	-1.57
	8218061	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.26	CHEMBL2543	Homo sapiens	Inhibition	%	2.26
	8218285	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.12	CHEMBL2543	Homo sapiens	Inhibition	%	4.12
	8218412	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.5	CHEMBL2543	Homo sapiens	Inhibition	%	1.5
	8218779	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	2.18	CHEMBL2543	Homo sapiens	Inhibition	%	2.18
	8218910	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.87	CHEMBL2543	Homo sapiens	Inhibition	%	0.87
	8219134	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.66	CHEMBL2543	Homo sapiens	Inhibition	%	1.66
	8219294	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-2.28	CHEMBL2543	Homo sapiens	Inhibition	%	-2.28
	8219544	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.12	CHEMBL2543	Homo sapiens	Inhibition	%	4.12
	8219705	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.25	CHEMBL2543	Homo sapiens	Inhibition	%	4.25
	8219929	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.12	CHEMBL2543	Homo sapiens	Inhibition	%	6.12
	8220098	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.15	CHEMBL2543	Homo sapiens	Inhibition	%	3.15
	8220451	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.19	CHEMBL2543	Homo sapiens	Inhibition	%	4.19
	8220565	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.58	CHEMBL2543	Homo sapiens	Inhibition	%	4.58
	8220927	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	8.01	CHEMBL2543	Homo sapiens	Inhibition	%	8.01
	8221063	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-1.82	CHEMBL2543	Homo sapiens	Inhibition	%	-1.82
	8221287	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.61	CHEMBL2543	Homo sapiens	Inhibition	%	-0.61
	8221420	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.68	CHEMBL2543	Homo sapiens	Inhibition	%	2.68
	8221809	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.78	CHEMBL2543	Homo sapiens	Inhibition	%	0.78
	8221940	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.78	CHEMBL2543	Homo sapiens	Inhibition	%	3.78
	8222262	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.75	CHEMBL2543	Homo sapiens	Inhibition	%	2.75
	8222620	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.8	CHEMBL2543	Homo sapiens	Inhibition	%	2.8
	8222738	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	8.69	CHEMBL2543	Homo sapiens	Inhibition	%	8.69
	8222962	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.19	CHEMBL2543	Homo sapiens	Inhibition	%	1.19
	8223106	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	1.65	CHEMBL2543	Homo sapiens	Inhibition	%	1.65
	8223459	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.09	CHEMBL2543	Homo sapiens	Inhibition	%	2.09
	8223620	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-2.36	CHEMBL2543	Homo sapiens	Inhibition	%	-2.36
	8223870	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.92	CHEMBL2543	Homo sapiens	Inhibition	%	2.92
	8224256	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.87	CHEMBL2543	Homo sapiens	Inhibition	%	-0.87
	8224426	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.75	CHEMBL2543	Homo sapiens	Inhibition	%	4.75
	8224785	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.09	CHEMBL2543	Homo sapiens	Inhibition	%	5.09
	8224899	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.31	CHEMBL2543	Homo sapiens	Inhibition	%	2.31
	8225123	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.61	CHEMBL2543	Homo sapiens	Inhibition	%	3.61
	8225257	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.99	CHEMBL2543	Homo sapiens	Inhibition	%	3.99
	8225619	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.64	CHEMBL2543	Homo sapiens	Inhibition	%	1.64
	8225754	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.83	CHEMBL2543	Homo sapiens	Inhibition	%	4.83
	8226136	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	6.64	CHEMBL2543	Homo sapiens	Inhibition	%	6.64
	8226261	CHEMBL1962014	GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.25	CHEMBL2543	Homo sapiens	Inhibition	%	2.25
	8226485	CHEMBL1962015	GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.89	CHEMBL2543	Homo sapiens	Inhibition	%	3.89
active	9507417	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	63.1	CHEMBL2543	Homo sapiens	pKi		7.2
inactive	9507418	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507419	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
active	9507420	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	316.23	CHEMBL2543	Homo sapiens	pKi		6.5
inactive	9507421	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507422	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507423	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507424	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507425	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507426	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507427	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9507428	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
active	9507429	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	158.49	CHEMBL2543	Homo sapiens	pKi		6.8
inactive	9507430	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507431	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	398.11	CHEMBL2543	Homo sapiens	pKi		6.4
inactive	9507432	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507433	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	100.0	CHEMBL2543	Homo sapiens	pKi		7.0
inactive	9507434	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507435	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
active	9507436	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
active	9507437	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
inactive	9507438	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507439	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507440	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	63.1	CHEMBL2543	Homo sapiens	pKi		7.2
inactive	9507441	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507442	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507443	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507444	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507445	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507446	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9507447	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
inactive	9507448	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507449	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507450	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9507451	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	398.11	CHEMBL2543	Homo sapiens	pKi		6.4
inactive	9507452	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507453	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507454	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507455	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507456	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9507457	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507458	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507459	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507460	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	3.981	CHEMBL2543	Homo sapiens	pKi		8.4
inactive	9507461	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507462	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
inactive	9507463	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507464	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507465	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507466	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507467	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507468	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507469	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9507470	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507471	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9507472	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507473	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9507474	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9507475	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511392	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511393	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9511394	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511395	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	125.89	CHEMBL2543	Homo sapiens	pKi		6.9
inactive	9511396	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511397	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511398	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511399	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511400	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
active	9511401	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
inactive	9511402	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511403	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511404	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
inactive	9511405	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511406	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	158.49	CHEMBL2543	Homo sapiens	pKi		6.8
active	9511407	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9511408	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511409	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511410	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511411	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511412	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
inactive	9511413	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511414	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9511415	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511416	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511417	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9511418	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511419	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9511420	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511421	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511422	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511423	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9511424	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511425	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511426	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511427	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
inactive	9511428	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511429	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
active	9511430	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9511431	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511432	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511433	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511434	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511435	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9511436	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511437	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
active	9511438	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9511439	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511440	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511441	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511442	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511443	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511444	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511445	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
active	9511446	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9511447	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511448	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9511449	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511450	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511451	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9511452	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9511453	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511454	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511455	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511456	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	794.33	CHEMBL2543	Homo sapiens	pKi		6.1
inactive	9511457	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511458	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511459	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511460	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511461	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9511462	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	251.19	CHEMBL2543	Homo sapiens	pKi		6.6
active	9511463	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
inactive	9511464	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511465	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9511466	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511467	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511468	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511469	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511470	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511471	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511472	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511473	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511474	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511475	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511476	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	316.23	CHEMBL2543	Homo sapiens	pKi		6.5
active	9511477	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
active	9511478	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511479	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511480	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511481	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511482	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	39.81	CHEMBL2543	Homo sapiens	pKi		7.4
inactive	9511483	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511484	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
active	9511485	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
active	9511486	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511487	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511488	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511489	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	25.12	CHEMBL2543	Homo sapiens	pKi		7.6
inactive	9511490	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511491	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9511492	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511493	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511494	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
inactive	9511495	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511496	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
inactive	9511497	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511498	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511499	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511500	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511501	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511502	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511503	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511504	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9511505	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
active	9511506	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511507	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511508	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511509	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511510	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9511511	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
inactive	9511512	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511513	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511514	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511515	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511516	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511517	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511518	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511519	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511520	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511521	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511522	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511523	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511524	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511525	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511526	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	251.19	CHEMBL2543	Homo sapiens	pKi		6.6
inactive	9511527	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511528	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511529	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511530	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511531	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511532	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511533	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511534	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511535	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9511536	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511537	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9511538	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511539	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
active	9511540	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511541	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511542	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9511543	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511544	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	31.62	CHEMBL2543	Homo sapiens	pKi		7.5
active	9511545	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	63.1	CHEMBL2543	Homo sapiens	pKi		7.2
inactive	9511546	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511547	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
active	9511548	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
active	9511549	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
inactive	9511550	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511551	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511552	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	158.49	CHEMBL2543	Homo sapiens	pKi		6.8
inactive	9511553	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511554	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	=	Ki	nM	794.33	CHEMBL2543	Homo sapiens	pKi		6.1
inactive	9511555	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511556	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511557	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511558	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9511559	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511560	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
inactive	9511561	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511562	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511563	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	251.19	CHEMBL2543	Homo sapiens	pKi		6.6
inactive	9511564	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511565	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	251.19	CHEMBL2543	Homo sapiens	pKi		6.6
inactive	9511566	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511567	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511568	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
inactive	9511569	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511570	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
active	9511571	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9511572	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
active	9511573	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9511574	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511575	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511576	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511577	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511578	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511579	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511580	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511581	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
inactive	9511582	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511583	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511584	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511585	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9511586	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511587	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511588	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	398.11	CHEMBL2543	Homo sapiens	pKi		6.4
active	9511589	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	6.31	CHEMBL2543	Homo sapiens	pKi		8.2
inactive	9511590	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511591	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511592	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511593	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	25.12	CHEMBL2543	Homo sapiens	pKi		7.6
inactive	9511594	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511595	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9511596	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511597	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511598	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	1584.89	CHEMBL2543	Homo sapiens	pKi		5.8
active	9511599	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9511600	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511601	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511602	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511603	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511604	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511605	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511606	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	316.23	CHEMBL2543	Homo sapiens	pKi		6.5
inactive	9511607	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511608	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511609	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
active	9511610	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	398.11	CHEMBL2543	Homo sapiens	pKi		6.4
active	9511611	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9511612	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9511613	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511614	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
inactive	9511615	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511616	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511617	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	=	Ki	nM	1584.89	CHEMBL2543	Homo sapiens	pKi		5.8
inactive	9511618	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511619	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	=	Ki	nM	251.19	CHEMBL2543	Homo sapiens	pKi		6.6
inactive	9511620	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511621	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9511622	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9511623	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511624	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511625	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511626	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
inactive	9511627	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9511628	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9511629	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
inactive	9511630	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515541	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
active	9515542	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9515543	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515544	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
inactive	9515545	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515546	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
inactive	9515547	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515548	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515549	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	398.11	CHEMBL2543	Homo sapiens	pKi		6.4
active	9515550	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
active	9515551	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	1584.89	CHEMBL2543	Homo sapiens	pKi		5.8
active	9515552	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
active	9515553	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9515554	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515555	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
inactive	9515556	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515557	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
inactive	9515558	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515559	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515560	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
active	9515561	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9515562	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515563	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515564	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515565	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9515566	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515567	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9515568	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515569	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515570	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9515571	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515572	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515573	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515574	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
inactive	9515575	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515576	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515577	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515578	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9515579	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515580	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515581	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515582	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515583	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515584	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515585	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	794.33	CHEMBL2543	Homo sapiens	pKi		6.1
inactive	9515586	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515587	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515588	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515589	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515590	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515591	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9515592	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515593	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515594	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515595	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9515596	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
inactive	9515597	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515598	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
inactive	9515599	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515600	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	398.11	CHEMBL2543	Homo sapiens	pKi		6.4
inactive	9515601	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515602	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9515603	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515604	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9515605	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515606	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
inactive	9515607	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515608	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515609	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	39.81	CHEMBL2543	Homo sapiens	pKi		7.4
inactive	9515610	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515611	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515612	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9515613	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515614	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
active	9515615	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9515616	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515617	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1(N2CCC(c3ccccc3)CC2)CCN(C(=O)CNc2ncnc3cc(Cl)c(Cl)cc23)C1		CHEMBL1964623	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9515618	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515619	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9515620	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515621	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515622	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9515623	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9515624	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515625	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515626	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515627	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515628	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9515629	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515630	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515631	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515632	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515633	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515634	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515635	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515636	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515637	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515638	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515639	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515640	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
inactive	9515641	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515642	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
active	9515643	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
inactive	9515644	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515645	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9515646	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
inactive	9515647	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515648	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	1584.89	CHEMBL2543	Homo sapiens	pKi		5.8
inactive	9515649	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515650	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515651	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515652	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515653	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515654	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515655	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
active	9515656	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
inactive	9515657	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515658	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	79.43	CHEMBL2543	Homo sapiens	pKi		7.1
active	9515659	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
active	9515660	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
active	9515661	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	63.1	CHEMBL2543	Homo sapiens	pKi		7.2
inactive	9515662	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515663	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
active	9515664	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9515665	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515666	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515667	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9515668	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515669	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515670	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9515671	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515672	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
active	9515673	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	794.33	CHEMBL2543	Homo sapiens	pKi		6.1
inactive	9515674	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515675	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
inactive	9515676	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515677	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515678	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515679	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515680	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515681	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	=	Ki	nM	100.0	CHEMBL2543	Homo sapiens	pKi		7.0
active	9515682	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9515683	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	251.19	CHEMBL2543	Homo sapiens	pKi		6.6
inactive	9515684	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515685	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	6.31	CHEMBL2543	Homo sapiens	pKi		8.2
active	9515686	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	251.19	CHEMBL2543	Homo sapiens	pKi		6.6
inactive	9515687	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515688	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
active	9515689	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
active	9515690	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	1584.89	CHEMBL2543	Homo sapiens	pKi		5.8
active	9515691	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
inactive	9515692	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515693	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515694	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515695	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515696	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515697	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9515698	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515699	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
inactive	9515700	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515701	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9515702	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
active	9515703	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9515704	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515705	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515706	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	1584.89	CHEMBL2543	Homo sapiens	pKi		5.8
inactive	9515707	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515708	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515709	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515710	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515711	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515712	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515713	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	50.12	CHEMBL2543	Homo sapiens	pKi		7.3
inactive	9515714	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515715	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515716	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515717	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515718	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515719	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)c1cccc(-c2cnc3ccccc3c2)c1		CHEMBL2007336	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9515720	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515721	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515722	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515723	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515724	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
active	9515725	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	158.49	CHEMBL2543	Homo sapiens	pKi		6.8
active	9515726	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9515727	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515728	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9515729	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515730	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
active	9515731	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	=	Ki	nM	199.53	CHEMBL2543	Homo sapiens	pKi		6.7
inactive	9515732	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515733	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515734	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515735	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
active	9515736	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9515737	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
active	9515738	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9515739	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515740	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515741	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9515742	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515743	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515744	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515745	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
active	9515746	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
inactive	9515747	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515748	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515749	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515750	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515751	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515752	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515753	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515754	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515755	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	630.96	CHEMBL2543	Homo sapiens	pKi		6.2
inactive	9515756	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515757	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	=	Ki	nM	1584.89	CHEMBL2543	Homo sapiens	pKi		5.8
active	9515758	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	=	Ki	nM	794.33	CHEMBL2543	Homo sapiens	pKi		6.1
inactive	9515759	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515760	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9515761	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	7.943	CHEMBL2543	Homo sapiens	pKi		8.1
inactive	9515762	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515763	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
inactive	9515764	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515765	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	125.89	CHEMBL2543	Homo sapiens	pKi		6.9
inactive	9515766	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515767	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515768	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515769	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
active	9515770	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	316.23	CHEMBL2543	Homo sapiens	pKi		6.5
active	9515771	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
active	9515772	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	=	Ki	nM	39.81	CHEMBL2543	Homo sapiens	pKi		7.4
active	9515773	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	316.23	CHEMBL2543	Homo sapiens	pKi		6.5
active	9515774	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	3981.07	CHEMBL2543	Homo sapiens	pKi		5.4
inactive	9515775	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9515776	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	19.95	CHEMBL2543	Homo sapiens	pKi		7.7
inactive	9515777	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515778	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9515779	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519683	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
inactive	9519684	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519685	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519686	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
active	9519687	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	50.12	CHEMBL2543	Homo sapiens	pKi		7.3
inactive	9519688	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519689	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
inactive	9519690	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519691	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
active	9519692	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9519693	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519694	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519695	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519696	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519697	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9519698	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519699	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519700	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519701	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9519702	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519703	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519704	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	1000.0	CHEMBL2543	Homo sapiens	pKi		6.0
active	9519705	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	3.981	CHEMBL2543	Homo sapiens	pKi		8.4
active	9519706	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	25.12	CHEMBL2543	Homo sapiens	pKi		7.6
active	9519707	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	1258.93	CHEMBL2543	Homo sapiens	pKi		5.9
inactive	9519708	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519709	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	501.19	CHEMBL2543	Homo sapiens	pKi		6.3
inactive	9519710	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519711	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519712	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519713	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	794.33	CHEMBL2543	Homo sapiens	pKi		6.1
inactive	9519714	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519715	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519716	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519717	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519718	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519719	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519720	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519721	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519722	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9519723	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519724	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	=	Ki	nM	31.62	CHEMBL2543	Homo sapiens	pKi		7.5
inactive	9519725	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519726	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519727	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519728	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519729	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9519730	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519731	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	1584.89	CHEMBL2543	Homo sapiens	pKi		5.8
inactive	9519732	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519733	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519734	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	=	Ki	nM	794.33	CHEMBL2543	Homo sapiens	pKi		6.1
active	9519735	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	1584.89	CHEMBL2543	Homo sapiens	pKi		5.8
active	9519736	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	5011.87	CHEMBL2543	Homo sapiens	pKi		5.3
active	9519737	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	=	Ki	nM	3162.28	CHEMBL2543	Homo sapiens	pKi		5.5
inactive	9519738	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519739	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	1995.26	CHEMBL2543	Homo sapiens	pKi		5.7
inactive	9519740	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519741	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	2511.89	CHEMBL2543	Homo sapiens	pKi		5.6
inactive	9519742	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519743	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519744	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	79.43	CHEMBL2543	Homo sapiens	pKi		7.1
inactive	9519745	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519746	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519747	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519748	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
inactive	9519749	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	7943.28	CHEMBL2543	Homo sapiens	pKi		5.1
active	9519750	CHEMBL1963686	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	=	Ki	nM	6309.57	CHEMBL2543	Homo sapiens	pKi		5.2
	10838678	CHEMBL2014904	Inhibition of CK1g2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	60.0	CHEMBL2543	Homo sapiens	INH	%	60.0
	10983974	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	N#Cc1ccc2nc(Nc3ccc(Oc4ncccc4C(F)(F)F)cc3)[nH]c2c1		CHEMBL2071607	=	IC50	nM	6560.0	CHEMBL2543	Homo sapiens	IC50	uM	6.56
	10983975	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	N#Cc1ccc2nc(Nc3ccc(-c4ccccc4)cc3)[nH]c2c1		CHEMBL2071609	=	IC50	nM	4890.0	CHEMBL2543	Homo sapiens	IC50	uM	4.89
	10983976	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	N#Cc1ccc2nc(Nc3ccc(-c4cccnc4F)cc3)[nH]c2c1		CHEMBL2071610	=	IC50	nM	1170.0	CHEMBL2543	Homo sapiens	IC50	uM	1.17
	10983977	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	Cn1cc(-c2ccc(Nc3nc4ccc(C#N)cc4[nH]3)cc2)cn1		CHEMBL2071611	=	IC50	nM	1450.0	CHEMBL2543	Homo sapiens	IC50	uM	1.45
	10983978	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL2071612	=	IC50	nM	1510.0	CHEMBL2543	Homo sapiens	IC50	uM	1.51
	10983979	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	Cc1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL2071613	=	IC50	nM	4540.0	CHEMBL2543	Homo sapiens	IC50	uM	4.54
	10983980	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	CC(C)(O)c1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL2071614	=	IC50	nM	700.0	CHEMBL2543	Homo sapiens	IC50	uM	0.7
	10983981	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3[nH]2)c(F)c1		CHEMBL2071615	=	IC50	nM	10100.0	CHEMBL2543	Homo sapiens	IC50	uM	10.1
Not Determined	10983982	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	Cc1cc(C(C)(C)C)ccc1Nc1nc2ccc(C#N)cc2[nH]1		CHEMBL2071616		IC50			CHEMBL2543	Homo sapiens	IC50		
	10983983	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	CC(C)(C)c1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1		CHEMBL2071618	=	IC50	nM	2340.0	CHEMBL2543	Homo sapiens	IC50	uM	2.34
	10983984	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	Cc1cc2nc(Nc3ccc(C(C)(C)C)cc3)[nH]c2cc1C#N		CHEMBL2071622	=	IC50	nM	13000.0	CHEMBL2543	Homo sapiens	IC50	uM	13.0
	10983985	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3o2)cc1		CHEMBL2071623	=	IC50	nM	14900.0	CHEMBL2543	Homo sapiens	IC50	uM	14.9
	10983986	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3s2)cc1		CHEMBL2071624	=	IC50	nM	3830.0	CHEMBL2543	Homo sapiens	IC50	uM	3.83
	10983987	CHEMBL2072010	Inhibition of CK1gamma2 expressed in HEK293 cells assessed as inhibition of LRP6 Thr1479 phosphorylation by immunoblotting	B	CC(C)(C)c1ccc(Nc2cn3cc(C#N)ccc3n2)cc1		CHEMBL2071625	=	IC50	nM	9100.0	CHEMBL2543	Homo sapiens	IC50	uM	9.1
	12046269	CHEMBL2156506	Inhibition of CK1gamma2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	2.3	CHEMBL2543	Homo sapiens	INH	%	2.3
	12170830	CHEMBL2212697	Inhibition of CK1gamma2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	81.0	CHEMBL2543	Homo sapiens	Activity	%	81.0
	12172131	CHEMBL2213957	Inhibition of CK1gamma2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	77.0	CHEMBL2543	Homo sapiens	Activity	%	77.0
	12173674	CHEMBL2209310	Inhibition of CSNK1G2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	27.0	CHEMBL2543	Homo sapiens	Activity	%	27.0
	12180196	CHEMBL2211467	Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminescence analysis	B	COc1cnc(-c2cnc3ccccc3c2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203552	=	IC50	nM	348.0	CHEMBL2543	Homo sapiens	IC50	nM	348.0
	12180201	CHEMBL2211457	Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured after 18 to 24 hrs by luciferase reporter gene assay	B	COc1cnc(COc2cc(F)c(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203565	=	IC50	nM	44.0	CHEMBL2543	Homo sapiens	IC50	uM	0.044
	12180202	CHEMBL2211457	Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured after 18 to 24 hrs by luciferase reporter gene assay	B	COc1cnc(COc2ccc(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203564	=	IC50	nM	537.0	CHEMBL2543	Homo sapiens	IC50	uM	0.537
	12180203	CHEMBL2211457	Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured after 18 to 24 hrs by luciferase reporter gene assay	B	COc1cnc(COc2ccc(F)c(F)c2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203563	=	IC50	nM	254.0	CHEMBL2543	Homo sapiens	IC50	uM	0.254
	12180204	CHEMBL2211457	Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured after 18 to 24 hrs by luciferase reporter gene assay	B	COc1cnc(COc2ccc(F)cc2F)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203562	=	IC50	nM	394.0	CHEMBL2543	Homo sapiens	IC50	uM	0.394
	12180205	CHEMBL2211457	Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured after 18 to 24 hrs by luciferase reporter gene assay	B	COc1cnc(COc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203561	=	IC50	nM	584.0	CHEMBL2543	Homo sapiens	IC50	uM	0.584
	12180206	CHEMBL2211457	Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured after 18 to 24 hrs by luciferase reporter gene assay	B	COc1cnc(CCc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203560	=	IC50	nM	1300.0	CHEMBL2543	Homo sapiens	IC50	uM	1.3
	12180207	CHEMBL2211457	Inhibition of CK1-gamma2 in human RKO cell assessed as inhibition of Wnt3a-induced Wnt signaling treated 1 hr prior to Wnt3a ligand addition measured after 18 to 24 hrs by luciferase reporter gene assay	B	COc1cnc(-c2cnc3ccccc3c2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203552	>	IC50	nM	3333.0	CHEMBL2543	Homo sapiens	IC50	nM	3333.0
	12180241	CHEMBL2211467	Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminescence analysis	B	COc1cnc(COc2cc(F)c(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203565	=	IC50	nM	87.0	CHEMBL2543	Homo sapiens	IC50	uM	0.087
Not Determined	12180242	CHEMBL2211467	Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminescence analysis	B	COc1cnc(COc2ccc(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203564		IC50			CHEMBL2543	Homo sapiens	IC50		
	12180243	CHEMBL2211467	Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminescence analysis	B	COc1cnc(COc2ccc(F)c(F)c2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203563	=	IC50	nM	200.0	CHEMBL2543	Homo sapiens	IC50	uM	0.2
Not Determined	12180244	CHEMBL2211467	Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminescence analysis	B	COc1cnc(COc2ccc(F)cc2F)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203562		IC50			CHEMBL2543	Homo sapiens	IC50		
Not Determined	12180245	CHEMBL2211467	Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminescence analysis	B	COc1cnc(COc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203561		IC50			CHEMBL2543	Homo sapiens	IC50		
	12180246	CHEMBL2211467	Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminescence analysis	B	COc1cnc(CCc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203560	=	IC50	nM	840.0	CHEMBL2543	Homo sapiens	IC50	uM	0.84
	12181481	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(COc2cc(F)c(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203565	=	IC50	nM	4.0	CHEMBL2543	Homo sapiens	IC50	uM	0.004
	12181482	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(COc2ccc(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203564	=	IC50	nM	3.0	CHEMBL2543	Homo sapiens	IC50	uM	0.003
	12181483	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(COc2ccc(F)c(F)c2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203563	=	IC50	nM	5.0	CHEMBL2543	Homo sapiens	IC50	uM	0.005
	12181484	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(COc2ccc(F)cc2F)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203562	=	IC50	nM	3.0	CHEMBL2543	Homo sapiens	IC50	uM	0.003
	12181485	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(COc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203561	=	IC50	nM	5.0	CHEMBL2543	Homo sapiens	IC50	uM	0.005
	12181486	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(CCc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203560	=	IC50	nM	26.0	CHEMBL2543	Homo sapiens	IC50	uM	0.026
	12181487	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(COc2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203559	=	IC50	nM	24.0	CHEMBL2543	Homo sapiens	IC50	uM	0.024
	12181488	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(Oc2ccccc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203558	=	IC50	nM	853.0	CHEMBL2543	Homo sapiens	IC50	uM	0.853
	12181489	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(OCc2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203557	=	IC50	nM	80.0	CHEMBL2543	Homo sapiens	IC50	uM	0.08
	12181490	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(Nc2ccccc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203556	=	IC50	nM	8.0	CHEMBL2543	Homo sapiens	IC50	uM	0.008
	12181491	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(NCc2ccccc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203555	=	IC50	nM	33.0	CHEMBL2543	Homo sapiens	IC50	uM	0.033
	12181492	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(CCc2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203554	=	IC50	nM	17.0	CHEMBL2543	Homo sapiens	IC50	uM	0.017
	12181493	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(/C=C/c2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203553	=	IC50	nM	50.0	CHEMBL2543	Homo sapiens	IC50	uM	0.05
	12181494	CHEMBL2211471	Inhibition of CK1-gamma 2 using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 32 uM ATP	B	COc1cnc(-c2cnc3ccccc3c2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203552	=	IC50	nM	8.0	CHEMBL2543	Homo sapiens	IC50	nM	8.0
	12244456	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	106.0	CHEMBL2543	Homo sapiens	Residual Activity	%	106.0
	12244457	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	89.0	CHEMBL2543	Homo sapiens	Residual Activity	%	89.0
	12244458	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	84.0	CHEMBL2543	Homo sapiens	Residual Activity	%	84.0
	12244459	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	94.0	CHEMBL2543	Homo sapiens	Residual Activity	%	94.0
	12244460	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	103.0	CHEMBL2543	Homo sapiens	Residual Activity	%	103.0
	12244461	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	104.0	CHEMBL2543	Homo sapiens	Residual Activity	%	104.0
	12244462	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	98.0	CHEMBL2543	Homo sapiens	Residual Activity	%	98.0
	12244463	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	100.0	CHEMBL2543	Homo sapiens	Residual Activity	%	100.0
	12244464	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	94.0	CHEMBL2543	Homo sapiens	Residual Activity	%	94.0
	12244465	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	96.0	CHEMBL2543	Homo sapiens	Residual Activity	%	96.0
	12244466	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	87.0	CHEMBL2543	Homo sapiens	Residual Activity	%	87.0
	12244467	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	37.0	CHEMBL2543	Homo sapiens	Residual Activity	%	37.0
	12244468	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	89.0	CHEMBL2543	Homo sapiens	Residual Activity	%	89.0
	12244469	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	94.0	CHEMBL2543	Homo sapiens	Residual Activity	%	94.0
	12244470	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	96.0	CHEMBL2543	Homo sapiens	Residual Activity	%	96.0
	12244471	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	83.0	CHEMBL2543	Homo sapiens	Residual Activity	%	83.0
	12244472	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	109.0	CHEMBL2543	Homo sapiens	Residual Activity	%	109.0
	12244473	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	92.0	CHEMBL2543	Homo sapiens	Residual Activity	%	92.0
	12244474	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	90.0	CHEMBL2543	Homo sapiens	Residual Activity	%	90.0
	12244475	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	86.0	CHEMBL2543	Homo sapiens	Residual Activity	%	86.0
	12244476	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	98.0	CHEMBL2543	Homo sapiens	Residual Activity	%	98.0
	12244477	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	88.0	CHEMBL2543	Homo sapiens	Residual Activity	%	88.0
	12244478	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	89.0	CHEMBL2543	Homo sapiens	Residual Activity	%	89.0
	12244479	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	88.0	CHEMBL2543	Homo sapiens	Residual Activity	%	88.0
	12244480	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	94.0	CHEMBL2543	Homo sapiens	Residual Activity	%	94.0
	12244481	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	86.0	CHEMBL2543	Homo sapiens	Residual Activity	%	86.0
	12244482	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	52.0	CHEMBL2543	Homo sapiens	Residual Activity	%	52.0
	12244483	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	71.0	CHEMBL2543	Homo sapiens	Residual Activity	%	71.0
	12244484	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	87.0	CHEMBL2543	Homo sapiens	Residual Activity	%	87.0
	12244485	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12244486	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247076	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	80.0	CHEMBL2543	Homo sapiens	Residual Activity	%	80.0
	12247077	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	83.0	CHEMBL2543	Homo sapiens	Residual Activity	%	83.0
	12247078	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	102.0	CHEMBL2543	Homo sapiens	Residual Activity	%	102.0
	12247079	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	89.0	CHEMBL2543	Homo sapiens	Residual Activity	%	89.0
	12247080	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	94.0	CHEMBL2543	Homo sapiens	Residual Activity	%	94.0
	12247081	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	83.0	CHEMBL2543	Homo sapiens	Residual Activity	%	83.0
	12247082	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247083	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	101.0	CHEMBL2543	Homo sapiens	Residual Activity	%	101.0
	12247084	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	95.0	CHEMBL2543	Homo sapiens	Residual Activity	%	95.0
	12247085	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	107.0	CHEMBL2543	Homo sapiens	Residual Activity	%	107.0
	12247086	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	99.0	CHEMBL2543	Homo sapiens	Residual Activity	%	99.0
	12247087	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247088	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	79.0	CHEMBL2543	Homo sapiens	Residual Activity	%	79.0
	12247089	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	82.0	CHEMBL2543	Homo sapiens	Residual Activity	%	82.0
	12247090	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	107.0	CHEMBL2543	Homo sapiens	Residual Activity	%	107.0
	12247091	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	102.0	CHEMBL2543	Homo sapiens	Residual Activity	%	102.0
	12247092	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	51.0	CHEMBL2543	Homo sapiens	Residual Activity	%	51.0
	12247093	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	99.0	CHEMBL2543	Homo sapiens	Residual Activity	%	99.0
	12247094	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	108.0	CHEMBL2543	Homo sapiens	Residual Activity	%	108.0
	12247095	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	91.0	CHEMBL2543	Homo sapiens	Residual Activity	%	91.0
	12247096	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	83.0	CHEMBL2543	Homo sapiens	Residual Activity	%	83.0
	12247097	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	63.0	CHEMBL2543	Homo sapiens	Residual Activity	%	63.0
	12247098	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	91.0	CHEMBL2543	Homo sapiens	Residual Activity	%	91.0
	12247099	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	95.0	CHEMBL2543	Homo sapiens	Residual Activity	%	95.0
	12247100	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	70.0	CHEMBL2543	Homo sapiens	Residual Activity	%	70.0
	12247101	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	91.0	CHEMBL2543	Homo sapiens	Residual Activity	%	91.0
	12247102	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	91.0	CHEMBL2543	Homo sapiens	Residual Activity	%	91.0
	12247103	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	83.0	CHEMBL2543	Homo sapiens	Residual Activity	%	83.0
	12247104	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	81.0	CHEMBL2543	Homo sapiens	Residual Activity	%	81.0
	12247105	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	75.0	CHEMBL2543	Homo sapiens	Residual Activity	%	75.0
	12247106	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	82.0	CHEMBL2543	Homo sapiens	Residual Activity	%	82.0
	12247107	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	85.0	CHEMBL2543	Homo sapiens	Residual Activity	%	85.0
	12247108	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	86.0	CHEMBL2543	Homo sapiens	Residual Activity	%	86.0
	12247109	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	81.0	CHEMBL2543	Homo sapiens	Residual Activity	%	81.0
	12247110	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	85.0	CHEMBL2543	Homo sapiens	Residual Activity	%	85.0
	12247111	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	73.0	CHEMBL2543	Homo sapiens	Residual Activity	%	73.0
	12247112	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	81.0	CHEMBL2543	Homo sapiens	Residual Activity	%	81.0
	12247113	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	61.0	CHEMBL2543	Homo sapiens	Residual Activity	%	61.0
	12247114	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	78.0	CHEMBL2543	Homo sapiens	Residual Activity	%	78.0
	12247115	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	88.0	CHEMBL2543	Homo sapiens	Residual Activity	%	88.0
	12247116	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	80.0	CHEMBL2543	Homo sapiens	Residual Activity	%	80.0
	12247117	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	101.0	CHEMBL2543	Homo sapiens	Residual Activity	%	101.0
	12247118	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	91.0	CHEMBL2543	Homo sapiens	Residual Activity	%	91.0
	12247119	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	75.0	CHEMBL2543	Homo sapiens	Residual Activity	%	75.0
	12247120	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	77.0	CHEMBL2543	Homo sapiens	Residual Activity	%	77.0
	12247121	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	76.0	CHEMBL2543	Homo sapiens	Residual Activity	%	76.0
	12247122	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	30.0	CHEMBL2543	Homo sapiens	Residual Activity	%	30.0
	12247123	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	82.0	CHEMBL2543	Homo sapiens	Residual Activity	%	82.0
	12247124	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	73.0	CHEMBL2543	Homo sapiens	Residual Activity	%	73.0
	12247125	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247126	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	26.0	CHEMBL2543	Homo sapiens	Residual Activity	%	26.0
	12247127	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	86.0	CHEMBL2543	Homo sapiens	Residual Activity	%	86.0
	12247128	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	88.0	CHEMBL2543	Homo sapiens	Residual Activity	%	88.0
	12247129	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	107.0	CHEMBL2543	Homo sapiens	Residual Activity	%	107.0
	12247130	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	118.0	CHEMBL2543	Homo sapiens	Residual Activity	%	118.0
	12247131	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	87.0	CHEMBL2543	Homo sapiens	Residual Activity	%	87.0
	12247132	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	120.0	CHEMBL2543	Homo sapiens	Residual Activity	%	120.0
	12247133	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	70.0	CHEMBL2543	Homo sapiens	Residual Activity	%	70.0
	12247134	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	64.0	CHEMBL2543	Homo sapiens	Residual Activity	%	64.0
	12247135	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	97.0	CHEMBL2543	Homo sapiens	Residual Activity	%	97.0
	12247136	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	99.0	CHEMBL2543	Homo sapiens	Residual Activity	%	99.0
	12247137	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	62.0	CHEMBL2543	Homo sapiens	Residual Activity	%	62.0
	12247138	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	111.0	CHEMBL2543	Homo sapiens	Residual Activity	%	111.0
	12247139	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	112.0	CHEMBL2543	Homo sapiens	Residual Activity	%	112.0
	12247140	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	124.0	CHEMBL2543	Homo sapiens	Residual Activity	%	124.0
	12247141	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	103.0	CHEMBL2543	Homo sapiens	Residual Activity	%	103.0
	12247142	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	97.0	CHEMBL2543	Homo sapiens	Residual Activity	%	97.0
	12247143	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	96.0	CHEMBL2543	Homo sapiens	Residual Activity	%	96.0
	12247144	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	106.0	CHEMBL2543	Homo sapiens	Residual Activity	%	106.0
	12247145	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	40.0	CHEMBL2543	Homo sapiens	Residual Activity	%	40.0
	12247146	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	101.0	CHEMBL2543	Homo sapiens	Residual Activity	%	101.0
	12247147	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL2543	Homo sapiens	Residual Activity	%	108.0
	12247148	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	52.0	CHEMBL2543	Homo sapiens	Residual Activity	%	52.0
	12247149	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	75.0	CHEMBL2543	Homo sapiens	Residual Activity	%	75.0
	12247150	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	83.0	CHEMBL2543	Homo sapiens	Residual Activity	%	83.0
	12247151	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	42.0	CHEMBL2543	Homo sapiens	Residual Activity	%	42.0
	12247152	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	87.0	CHEMBL2543	Homo sapiens	Residual Activity	%	87.0
	12247153	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	121.0	CHEMBL2543	Homo sapiens	Residual Activity	%	121.0
	12247154	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	114.0	CHEMBL2543	Homo sapiens	Residual Activity	%	114.0
	12247155	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	102.0	CHEMBL2543	Homo sapiens	Residual Activity	%	102.0
	12247156	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	108.0	CHEMBL2543	Homo sapiens	Residual Activity	%	108.0
	12247157	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	66.0	CHEMBL2543	Homo sapiens	Residual Activity	%	66.0
	12247158	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	96.0	CHEMBL2543	Homo sapiens	Residual Activity	%	96.0
	12247159	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	70.0	CHEMBL2543	Homo sapiens	Residual Activity	%	70.0
	12247160	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	96.0	CHEMBL2543	Homo sapiens	Residual Activity	%	96.0
	12247161	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	100.0	CHEMBL2543	Homo sapiens	Residual Activity	%	100.0
	12247162	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	111.0	CHEMBL2543	Homo sapiens	Residual Activity	%	111.0
	12247163	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	89.0	CHEMBL2543	Homo sapiens	Residual Activity	%	89.0
	12247164	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	102.0	CHEMBL2543	Homo sapiens	Residual Activity	%	102.0
	12247165	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	60.0	CHEMBL2543	Homo sapiens	Residual Activity	%	60.0
	12247166	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	52.0	CHEMBL2543	Homo sapiens	Residual Activity	%	52.0
	12247167	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	4.0	CHEMBL2543	Homo sapiens	Residual Activity	%	4.0
	12247168	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	97.0	CHEMBL2543	Homo sapiens	Residual Activity	%	97.0
	12247169	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	77.0	CHEMBL2543	Homo sapiens	Residual Activity	%	77.0
	12247170	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	107.0	CHEMBL2543	Homo sapiens	Residual Activity	%	107.0
	12247171	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	22.0	CHEMBL2543	Homo sapiens	Residual Activity	%	22.0
	12247172	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	117.0	CHEMBL2543	Homo sapiens	Residual Activity	%	117.0
	12247173	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	83.0	CHEMBL2543	Homo sapiens	Residual Activity	%	83.0
	12247174	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-6.0	CHEMBL2543	Homo sapiens	Residual Activity	%	-6.0
	12247175	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	53.0	CHEMBL2543	Homo sapiens	Residual Activity	%	53.0
	12247176	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247177	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	70.0	CHEMBL2543	Homo sapiens	Residual Activity	%	70.0
	12247178	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	105.0	CHEMBL2543	Homo sapiens	Residual Activity	%	105.0
	12247179	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	100.0	CHEMBL2543	Homo sapiens	Residual Activity	%	100.0
	12247180	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	19.0	CHEMBL2543	Homo sapiens	Residual Activity	%	19.0
	12247181	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	96.0	CHEMBL2543	Homo sapiens	Residual Activity	%	96.0
	12247182	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	33.0	CHEMBL2543	Homo sapiens	Residual Activity	%	33.0
	12247183	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	71.0	CHEMBL2543	Homo sapiens	Residual Activity	%	71.0
	12247184	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	84.0	CHEMBL2543	Homo sapiens	Residual Activity	%	84.0
	12247185	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	106.0	CHEMBL2543	Homo sapiens	Residual Activity	%	106.0
	12247186	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	108.0	CHEMBL2543	Homo sapiens	Residual Activity	%	108.0
	12247187	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	88.0	CHEMBL2543	Homo sapiens	Residual Activity	%	88.0
	12247188	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	99.0	CHEMBL2543	Homo sapiens	Residual Activity	%	99.0
	12247189	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247190	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	81.0	CHEMBL2543	Homo sapiens	Residual Activity	%	81.0
	12247191	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	89.0	CHEMBL2543	Homo sapiens	Residual Activity	%	89.0
	12247192	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	87.0	CHEMBL2543	Homo sapiens	Residual Activity	%	87.0
	12247193	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	100.0	CHEMBL2543	Homo sapiens	Residual Activity	%	100.0
	12247194	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	116.0	CHEMBL2543	Homo sapiens	Residual Activity	%	116.0
	12247195	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	102.0	CHEMBL2543	Homo sapiens	Residual Activity	%	102.0
	12247196	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	104.0	CHEMBL2543	Homo sapiens	Residual Activity	%	104.0
	12247197	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL2543	Homo sapiens	Residual Activity	%	103.0
	12247198	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	86.0	CHEMBL2543	Homo sapiens	Residual Activity	%	86.0
	12247199	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	101.0	CHEMBL2543	Homo sapiens	Residual Activity	%	101.0
	12247200	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	103.0	CHEMBL2543	Homo sapiens	Residual Activity	%	103.0
	12247201	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	111.0	CHEMBL2543	Homo sapiens	Residual Activity	%	111.0
	12247202	CHEMBL2218992	Millipore: Percentage of residual kinase activity of CSNK1G2 at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	119.0	CHEMBL2543	Homo sapiens	Residual Activity	%	119.0
	12247203	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	90.0	CHEMBL2543	Homo sapiens	Residual Activity	%	90.0
	12247204	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	73.0	CHEMBL2543	Homo sapiens	Residual Activity	%	73.0
	12247205	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	51.0	CHEMBL2543	Homo sapiens	Residual Activity	%	51.0
	12247206	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	107.0	CHEMBL2543	Homo sapiens	Residual Activity	%	107.0
	12247207	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	61.0	CHEMBL2543	Homo sapiens	Residual Activity	%	61.0
	12247208	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	109.0	CHEMBL2543	Homo sapiens	Residual Activity	%	109.0
	12247209	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247210	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	80.0	CHEMBL2543	Homo sapiens	Residual Activity	%	80.0
	12247211	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	85.0	CHEMBL2543	Homo sapiens	Residual Activity	%	85.0
	12247212	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	68.0	CHEMBL2543	Homo sapiens	Residual Activity	%	68.0
	12247213	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	103.0	CHEMBL2543	Homo sapiens	Residual Activity	%	103.0
	12247214	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	11.0	CHEMBL2543	Homo sapiens	Residual Activity	%	11.0
	12247215	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	71.0	CHEMBL2543	Homo sapiens	Residual Activity	%	71.0
	12247216	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	76.0	CHEMBL2543	Homo sapiens	Residual Activity	%	76.0
	12247217	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	67.0	CHEMBL2543	Homo sapiens	Residual Activity	%	67.0
	12247218	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	74.0	CHEMBL2543	Homo sapiens	Residual Activity	%	74.0
	12247219	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	120.0	CHEMBL2543	Homo sapiens	Residual Activity	%	120.0
	12247220	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	87.0	CHEMBL2543	Homo sapiens	Residual Activity	%	87.0
	12247221	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	100.0	CHEMBL2543	Homo sapiens	Residual Activity	%	100.0
	12247222	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	76.0	CHEMBL2543	Homo sapiens	Residual Activity	%	76.0
	12247223	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	68.0	CHEMBL2543	Homo sapiens	Residual Activity	%	68.0
	12247224	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	71.0	CHEMBL2543	Homo sapiens	Residual Activity	%	71.0
	12247225	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	95.0	CHEMBL2543	Homo sapiens	Residual Activity	%	95.0
	12247226	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	87.0	CHEMBL2543	Homo sapiens	Residual Activity	%	87.0
	12247227	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	82.0	CHEMBL2543	Homo sapiens	Residual Activity	%	82.0
	12247228	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	68.0	CHEMBL2543	Homo sapiens	Residual Activity	%	68.0
	12247229	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	3.0	CHEMBL2543	Homo sapiens	Residual Activity	%	3.0
	12247230	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	35.0	CHEMBL2543	Homo sapiens	Residual Activity	%	35.0
	12247231	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	87.0	CHEMBL2543	Homo sapiens	Residual Activity	%	87.0
	12247232	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	92.0	CHEMBL2543	Homo sapiens	Residual Activity	%	92.0
	12247233	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	53.0	CHEMBL2543	Homo sapiens	Residual Activity	%	53.0
	12247234	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	73.0	CHEMBL2543	Homo sapiens	Residual Activity	%	73.0
	12247235	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	79.0	CHEMBL2543	Homo sapiens	Residual Activity	%	79.0
	12247236	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	73.0	CHEMBL2543	Homo sapiens	Residual Activity	%	73.0
	12247237	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247238	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL2543	Homo sapiens	Residual Activity	%	96.0
	12247239	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	75.0	CHEMBL2543	Homo sapiens	Residual Activity	%	75.0
	12247240	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	123.0	CHEMBL2543	Homo sapiens	Residual Activity	%	123.0
	12247241	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	100.0	CHEMBL2543	Homo sapiens	Residual Activity	%	100.0
	12247242	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	89.0	CHEMBL2543	Homo sapiens	Residual Activity	%	89.0
	12247243	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	107.0	CHEMBL2543	Homo sapiens	Residual Activity	%	107.0
	12247244	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	119.0	CHEMBL2543	Homo sapiens	Residual Activity	%	119.0
	12247245	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	70.0	CHEMBL2543	Homo sapiens	Residual Activity	%	70.0
	12247246	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	39.0	CHEMBL2543	Homo sapiens	Residual Activity	%	39.0
	12247247	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	70.0	CHEMBL2543	Homo sapiens	Residual Activity	%	70.0
	12247248	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247249	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	98.0	CHEMBL2543	Homo sapiens	Residual Activity	%	98.0
	12247250	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	8.0	CHEMBL2543	Homo sapiens	Residual Activity	%	8.0
	12247251	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	90.0	CHEMBL2543	Homo sapiens	Residual Activity	%	90.0
	12247252	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	81.0	CHEMBL2543	Homo sapiens	Residual Activity	%	81.0
	12247253	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	101.0	CHEMBL2543	Homo sapiens	Residual Activity	%	101.0
	12247254	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	65.0	CHEMBL2543	Homo sapiens	Residual Activity	%	65.0
	12247255	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	19.0	CHEMBL2543	Homo sapiens	Residual Activity	%	19.0
	12247256	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	100.0	CHEMBL2543	Homo sapiens	Residual Activity	%	100.0
	12247257	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	98.0	CHEMBL2543	Homo sapiens	Residual Activity	%	98.0
	12247258	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	61.0	CHEMBL2543	Homo sapiens	Residual Activity	%	61.0
	12247259	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	64.0	CHEMBL2543	Homo sapiens	Residual Activity	%	64.0
	12247260	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	67.0	CHEMBL2543	Homo sapiens	Residual Activity	%	67.0
	12247261	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	47.0	CHEMBL2543	Homo sapiens	Residual Activity	%	47.0
	12247262	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	73.0	CHEMBL2543	Homo sapiens	Residual Activity	%	73.0
	12247263	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	46.0	CHEMBL2543	Homo sapiens	Residual Activity	%	46.0
	12247264	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	68.0	CHEMBL2543	Homo sapiens	Residual Activity	%	68.0
	12247265	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	73.0	CHEMBL2543	Homo sapiens	Residual Activity	%	73.0
	12247266	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	87.0	CHEMBL2543	Homo sapiens	Residual Activity	%	87.0
	12247267	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	58.0	CHEMBL2543	Homo sapiens	Residual Activity	%	58.0
	12247268	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	53.0	CHEMBL2543	Homo sapiens	Residual Activity	%	53.0
	12247269	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	67.0	CHEMBL2543	Homo sapiens	Residual Activity	%	67.0
	12247270	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	76.0	CHEMBL2543	Homo sapiens	Residual Activity	%	76.0
	12247271	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	6.0	CHEMBL2543	Homo sapiens	Residual Activity	%	6.0
	12247272	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	93.0	CHEMBL2543	Homo sapiens	Residual Activity	%	93.0
	12247273	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	40.0	CHEMBL2543	Homo sapiens	Residual Activity	%	40.0
	12247274	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	70.0	CHEMBL2543	Homo sapiens	Residual Activity	%	70.0
	12247275	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	104.0	CHEMBL2543	Homo sapiens	Residual Activity	%	104.0
	12247276	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	94.0	CHEMBL2543	Homo sapiens	Residual Activity	%	94.0
	12247277	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	43.0	CHEMBL2543	Homo sapiens	Residual Activity	%	43.0
	12247278	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	129.0	CHEMBL2543	Homo sapiens	Residual Activity	%	129.0
	12247279	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	62.0	CHEMBL2543	Homo sapiens	Residual Activity	%	62.0
	12247280	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	0.0	CHEMBL2543	Homo sapiens	Residual Activity	%	0.0
	12247281	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	48.0	CHEMBL2543	Homo sapiens	Residual Activity	%	48.0
	12247282	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	35.0	CHEMBL2543	Homo sapiens	Residual Activity	%	35.0
	12247283	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	73.0	CHEMBL2543	Homo sapiens	Residual Activity	%	73.0
	12247284	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	-5.0	CHEMBL2543	Homo sapiens	Residual Activity	%	-5.0
	12247285	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	91.0	CHEMBL2543	Homo sapiens	Residual Activity	%	91.0
	12247286	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	95.0	CHEMBL2543	Homo sapiens	Residual Activity	%	95.0
	12247287	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	75.0	CHEMBL2543	Homo sapiens	Residual Activity	%	75.0
	12247288	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	94.0	CHEMBL2543	Homo sapiens	Residual Activity	%	94.0
	12247289	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	9.0	CHEMBL2543	Homo sapiens	Residual Activity	%	9.0
	12247290	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	71.0	CHEMBL2543	Homo sapiens	Residual Activity	%	71.0
	12247291	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	12.0	CHEMBL2543	Homo sapiens	Residual Activity	%	12.0
	12247292	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	20.0	CHEMBL2543	Homo sapiens	Residual Activity	%	20.0
	12247293	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	79.0	CHEMBL2543	Homo sapiens	Residual Activity	%	79.0
	12247294	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	85.0	CHEMBL2543	Homo sapiens	Residual Activity	%	85.0
	12247295	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	0.0	CHEMBL2543	Homo sapiens	Residual Activity	%	0.0
	12247296	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	90.0	CHEMBL2543	Homo sapiens	Residual Activity	%	90.0
	12247297	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	72.0	CHEMBL2543	Homo sapiens	Residual Activity	%	72.0
	12247298	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	110.0	CHEMBL2543	Homo sapiens	Residual Activity	%	110.0
	12247299	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	58.0	CHEMBL2543	Homo sapiens	Residual Activity	%	58.0
	12247300	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	97.0	CHEMBL2543	Homo sapiens	Residual Activity	%	97.0
	12247301	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	95.0	CHEMBL2543	Homo sapiens	Residual Activity	%	95.0
	12247302	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	98.0	CHEMBL2543	Homo sapiens	Residual Activity	%	98.0
	12247303	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	8.0	CHEMBL2543	Homo sapiens	Residual Activity	%	8.0
	12247304	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	60.0	CHEMBL2543	Homo sapiens	Residual Activity	%	60.0
	12247305	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	102.0	CHEMBL2543	Homo sapiens	Residual Activity	%	102.0
	12247306	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	54.0	CHEMBL2543	Homo sapiens	Residual Activity	%	54.0
	12247307	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	67.0	CHEMBL2543	Homo sapiens	Residual Activity	%	67.0
	12247308	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	41.0	CHEMBL2543	Homo sapiens	Residual Activity	%	41.0
	12247309	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	1.0	CHEMBL2543	Homo sapiens	Residual Activity	%	1.0
	12247310	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	76.0	CHEMBL2543	Homo sapiens	Residual Activity	%	76.0
	12247311	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	85.0	CHEMBL2543	Homo sapiens	Residual Activity	%	85.0
	12247312	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	83.0	CHEMBL2543	Homo sapiens	Residual Activity	%	83.0
	12247313	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	84.0	CHEMBL2543	Homo sapiens	Residual Activity	%	84.0
	12247314	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	86.0	CHEMBL2543	Homo sapiens	Residual Activity	%	86.0
	12249980	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	15.0	CHEMBL2543	Homo sapiens	Residual Activity	%	15.0
	12249981	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	68.0	CHEMBL2543	Homo sapiens	Residual Activity	%	68.0
	12249982	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	32.0	CHEMBL2543	Homo sapiens	Residual Activity	%	32.0
	12249983	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	90.0	CHEMBL2543	Homo sapiens	Residual Activity	%	90.0
	12249984	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	75.0	CHEMBL2543	Homo sapiens	Residual Activity	%	75.0
	12249985	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	85.0	CHEMBL2543	Homo sapiens	Residual Activity	%	85.0
	12249986	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	28.0	CHEMBL2543	Homo sapiens	Residual Activity	%	28.0
	12249987	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	44.0	CHEMBL2543	Homo sapiens	Residual Activity	%	44.0
	12249988	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	18.0	CHEMBL2543	Homo sapiens	Residual Activity	%	18.0
	12249989	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	3.0	CHEMBL2543	Homo sapiens	Residual Activity	%	3.0
	12249990	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	-9.0	CHEMBL2543	Homo sapiens	Residual Activity	%	-9.0
	12249991	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	72.0	CHEMBL2543	Homo sapiens	Residual Activity	%	72.0
	12249992	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	24.0	CHEMBL2543	Homo sapiens	Residual Activity	%	24.0
	12249993	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	70.0	CHEMBL2543	Homo sapiens	Residual Activity	%	70.0
	12249994	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	-13.0	CHEMBL2543	Homo sapiens	Residual Activity	%	-13.0
	12249995	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	96.0	CHEMBL2543	Homo sapiens	Residual Activity	%	96.0
	12249996	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	36.0	CHEMBL2543	Homo sapiens	Residual Activity	%	36.0
	12249997	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-9.0	CHEMBL2543	Homo sapiens	Residual Activity	%	-9.0
	12249998	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	5.0	CHEMBL2543	Homo sapiens	Residual Activity	%	5.0
	12249999	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	65.0	CHEMBL2543	Homo sapiens	Residual Activity	%	65.0
	12250000	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	6.0	CHEMBL2543	Homo sapiens	Residual Activity	%	6.0
	12250001	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	91.0	CHEMBL2543	Homo sapiens	Residual Activity	%	91.0
	12250002	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	48.0	CHEMBL2543	Homo sapiens	Residual Activity	%	48.0
	12250003	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	-12.0	CHEMBL2543	Homo sapiens	Residual Activity	%	-12.0
	12250004	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	53.0	CHEMBL2543	Homo sapiens	Residual Activity	%	53.0
	12250005	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	-6.0	CHEMBL2543	Homo sapiens	Residual Activity	%	-6.0
	12250006	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	23.0	CHEMBL2543	Homo sapiens	Residual Activity	%	23.0
	12250007	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	21.0	CHEMBL2543	Homo sapiens	Residual Activity	%	21.0
	12250008	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	90.0	CHEMBL2543	Homo sapiens	Residual Activity	%	90.0
	12250009	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	99.0	CHEMBL2543	Homo sapiens	Residual Activity	%	99.0
	12250010	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	38.0	CHEMBL2543	Homo sapiens	Residual Activity	%	38.0
	12250011	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	52.0	CHEMBL2543	Homo sapiens	Residual Activity	%	52.0
	12250012	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	63.0	CHEMBL2543	Homo sapiens	Residual Activity	%	63.0
	12250013	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	79.0	CHEMBL2543	Homo sapiens	Residual Activity	%	79.0
	12250014	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	75.0	CHEMBL2543	Homo sapiens	Residual Activity	%	75.0
	12250015	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	22.0	CHEMBL2543	Homo sapiens	Residual Activity	%	22.0
	12250016	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	65.0	CHEMBL2543	Homo sapiens	Residual Activity	%	65.0
	12250017	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	97.0	CHEMBL2543	Homo sapiens	Residual Activity	%	97.0
	12250018	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	59.0	CHEMBL2543	Homo sapiens	Residual Activity	%	59.0
	12250019	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	45.0	CHEMBL2543	Homo sapiens	Residual Activity	%	45.0
	12250020	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	88.0	CHEMBL2543	Homo sapiens	Residual Activity	%	88.0
	12250021	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	80.0	CHEMBL2543	Homo sapiens	Residual Activity	%	80.0
	12250022	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	72.0	CHEMBL2543	Homo sapiens	Residual Activity	%	72.0
	12250023	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	70.0	CHEMBL2543	Homo sapiens	Residual Activity	%	70.0
	12250024	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	51.0	CHEMBL2543	Homo sapiens	Residual Activity	%	51.0
	12250025	CHEMBL2218993	Millipore: Percentage of residual kinase activity of CSNK1G2 at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	85.0	CHEMBL2543	Homo sapiens	Residual Activity	%	85.0
	12700123	CHEMBL2344137	Inhibition of recombinant CSNK1G2 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	12.0	CHEMBL2543	Homo sapiens	INH	%	12.0
	12728873	CHEMBL2349957	Inhibition of CK1gamma2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	100.0	CHEMBL2543	Homo sapiens	Activity	%	100.0
	12730015	CHEMBL2353889	Inhibition of CK1gamma2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	90.0	CHEMBL2543	Homo sapiens	Activity	%	90.0
	12730263	CHEMBL2349957	Inhibition of CK1gamma2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL2543	Homo sapiens	Activity	%	94.0
	12730895	CHEMBL2349823	Inhibition of CK1g2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	101.0	CHEMBL2543	Homo sapiens	Activity	%	101.0
	13342443	CHEMBL2394170	Competitive binding affinity to CSNK1G2 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	10.0	CHEMBL2543	Homo sapiens	Activity	%	10.0
	13375902	CHEMBL2405311	Inhibition of CK1gamma2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	4.0	CHEMBL2543	Homo sapiens	INH	%	4.0
	13442379	CHEMBL2428001	Competitive binding affinity to CSNK1G2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	13445514	CHEMBL2428001	Competitive binding affinity to CSNK1G2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	74.0	CHEMBL2543	Homo sapiens	INH	%	74.0
	13448569	CHEMBL2428001	Competitive binding affinity to CSNK1G2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	13448705	CHEMBL2428001	Competitive binding affinity to CSNK1G2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	76.0	CHEMBL2543	Homo sapiens	INH	%	76.0
	13451500	CHEMBL2428001	Competitive binding affinity to CSNK1G2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	100.0	CHEMBL2543	Homo sapiens	INH	%	100.0
	13454685	CHEMBL2428001	Competitive binding affinity to CSNK1G2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	13872182	CHEMBL3101934	Inhibition of human CK1gamma2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	114.0	CHEMBL2543	Homo sapiens	Activity	%	114.0
Active	14577989	CHEMBL3239322	Inhibition of CK-1gamma2 (unknown origin) at 10 uM by KinomeScan analysis	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235538		Inhibition	%		CHEMBL2543	Homo sapiens	INH		
Active	14577990	CHEMBL3239322	Inhibition of CK-1gamma2 (unknown origin) at 10 uM by KinomeScan analysis	B	O=C(Cc1ccccc1Cl)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235542		Inhibition	%		CHEMBL2543	Homo sapiens	INH		
	14582466	CHEMBL3240426	Inhibition of human CK1gamma2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	99.5	CHEMBL2543	Homo sapiens	Activity	%	99.5
	14663253	CHEMBL3270859	Inhibition of CSNK1G2 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	77.0	CHEMBL2543	Homo sapiens	INH	%	77.0
	14663254	CHEMBL3270859	Inhibition of CSNK1G2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	5.0	CHEMBL2543	Homo sapiens	INH	%	5.0
	14663255	CHEMBL3270859	Inhibition of CSNK1G2 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	5.2	CHEMBL2543	Homo sapiens	INH	%	5.2
	15072435	CHEMBL3388058	Inhibition of CK1gamma2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	99.0	CHEMBL2543	Homo sapiens	Activity	%	99.0
	15104923	CHEMBL3386804	Inhibition of CSNK1G2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	8.2	CHEMBL2543	Homo sapiens	Activity	%	8.2
	15104924	CHEMBL3386804	Inhibition of CSNK1G2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337845	=	Activity	%	23.0	CHEMBL2543	Homo sapiens	Activity	%	23.0
	15236109	CHEMBL3424698	Inhibition of human Casein kinase 1 gamma 2 assessed as residual activity at 10 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N		CHEMBL1835439	=	Activity	%	100.0	CHEMBL2543	Homo sapiens	Activity	%	100.0
	15236129	CHEMBL3424698	Inhibition of human Casein kinase 1 gamma 2 assessed as residual activity at 10 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)[C@@H](C)O		CHEMBL3422705	=	Activity	%	87.0	CHEMBL2543	Homo sapiens	Activity	%	87.0
	15236163	CHEMBL3424698	Inhibition of human Casein kinase 1 gamma 2 assessed as residual activity at 10 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC(C)C		CHEMBL3422697	=	Activity	%	94.0	CHEMBL2543	Homo sapiens	Activity	%	94.0
	15236187	CHEMBL3424698	Inhibition of human Casein kinase 1 gamma 2 assessed as residual activity at 10 uM relative to control	B	CCCCCCCCC[C@@H](O)[C@@H](N)Cc1ccccc1		CHEMBL3422700	=	Activity	%	96.0	CHEMBL2543	Homo sapiens	Activity	%	96.0
	15258347	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	4.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	4.0
	15258407	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	-0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.1
	15258467	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	2.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.7
	15258527	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	3.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	3.3
	15258587	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	1.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.2
	15258647	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	1.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.6
	15258707	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	1.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.0
	15258767	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	1.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.0
	15258827	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	2.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.5
	15258887	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	3.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	3.6
	15258947	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.8	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.8
	15259007	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	2.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.5
	15259067	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	2.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.0
	15259127	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	2.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.6
	15259187	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	4.9	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	4.9
	15259247	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15259307	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	0.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.6
	15259367	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.6
	15259427	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15259487	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	3.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	3.4
	15259547	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	2.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.0
	15259607	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	1.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.0
	15259667	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	0.9	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.9
	15259727	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	4.9	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	4.9
	15259787	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15259847	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15259907	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259967	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15260027	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15260087	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.0
	15260147	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15260207	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	-0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.3
	15260267	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	2.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.3
	15260327	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15260387	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	-0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.3
	15260447	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	0.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.0
	15260507	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	5.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	5.1
	15260567	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	6.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	6.5
	15260627	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	1.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.1
	15260687	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	1.8	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.8
	15260747	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	-0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.1
	15260807	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	5.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	5.2
	15260867	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	8.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	8.0
	15260927	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	0.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.2
	15260987	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	0.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.0
	15261047	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	-0.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261107	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	-0.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261190	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	1.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.7
	15261250	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15261310	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15261370	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	0.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.6
	15261425	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	3.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	3.5
	15261485	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.1
	15261545	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	1.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.4
	15261605	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-0.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261678	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	0.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.6
	15261738	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.9	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.9
	15261798	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15261858	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15261914	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15261974	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15262034	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15262094	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	0.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.0
	15262167	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15262227	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	0.8	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.8
	15262287	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	3.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	3.7
	15262347	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15262407	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.6
	15262467	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.6
	15262527	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	1.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.1
	15262587	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	1.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.1
	15262647	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15262707	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	-0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262767	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.1
	15262827	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	2.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.7
	15262887	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	2.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.2
	15262947	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15263007	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	0.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.0
	15263067	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	0.8	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.8
	15263127	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15263187	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15263247	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	1.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.2
	15263307	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15263367	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15263403	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15263463	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.6
	15263518	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	2.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.5
	15263578	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15263638	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15263698	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	0.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.2
	15263772	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	0.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.6
	15263832	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15263892	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.8	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.8
	15263952	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	0.8	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.8
	15264006	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	1.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.1
	15264066	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-0.3
	15264126	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15264186	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15264259	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	1.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.6
	15264319	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15264379	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	2.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.3
	15264439	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	5.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	5.6
	15264495	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	1.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.3
	15264555	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.1
	15264615	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15264675	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.0
	15264747	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15264807	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15264867	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15264927	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	3.8	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	3.8
	15264983	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15265043	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	-3.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	-3.1
	15265103	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.1
	15265163	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	3.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	3.1
	15265236	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	4.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	4.5
	15265296	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15265356	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15265416	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	1.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.6
	15265472	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.1
	15265532	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.2
	15265592	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.1
	15265652	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.0
	15265724	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.6
	15265784	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	1.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.2
	15265844	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15265904	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15265961	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.1
	15266021	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.2
	15266081	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15266141	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	1.9	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.9
	15266201	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	2.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.5
	15266213	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	0.8	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.8
	15266273	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.1
	15266333	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15266393	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	1.6	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.6
	15266453	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	2.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	2.4
	15266508	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15266568	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15266628	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15266688	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15266761	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15266821	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15266881	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	0.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.5
	15266941	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15266996	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15267056	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15267116	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	0.3	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.3
	15267176	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	1.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.1
	15267249	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	1.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.0
	15267309	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	1.5	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	1.5
	15267369	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	0.8	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.8
	15267429	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	0.7	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.7
	15267484	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.2	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.2
	15267544	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.1	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.1
	15267604	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	0.0	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.0
	15267664	CHEMBL3430806	Delta TM value showing the stabilisation of CK1G2 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.4	CHEMBL2543	Homo sapiens	Thermal melting change	degrees C	0.4
	15754925	CHEMBL3631708	Inhibition of CK1gamma2 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	1.8	CHEMBL2543	Homo sapiens	INH	%	1.8
	15755870	CHEMBL3630647	Inhibition of CSNK1G2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	81.0	CHEMBL2543	Homo sapiens	Activity	%	81.0
	15756055	CHEMBL3632316	Inhibition of CK1gamma2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	34.5	CHEMBL2543	Homo sapiens	INH	%	34.5
	15757035	CHEMBL3632316	Inhibition of CK1gamma2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	20.07	CHEMBL2543	Homo sapiens	INH	%	20.07
	15758667	CHEMBL3632316	Inhibition of CK1gamma2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	11.42	CHEMBL2543	Homo sapiens	INH	%	11.42
	16413429	CHEMBL3743715	Inhibition of CKgamma2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2543	Homo sapiens	IC50	uM	10.0
	16425411	CHEMBL3749848	Inhibition of CK1 gamma2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	1.9	CHEMBL2543	Homo sapiens	INH	%	1.9
	16431784	CHEMBL3748988	Inhibition of human CK1gamma2 using [KRRRAL[pS]VASLPGL] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2543	Homo sapiens	IC50	uM	10.0
	16450791	CHEMBL3762309	Inhibition of CK1gamma2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	3.5	CHEMBL2543	Homo sapiens	INH	%	3.5
	16485715	CHEMBL3771443	Inhibition of human recombinant CSNK1G2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	97.0	CHEMBL2543	Homo sapiens	Activity	%	97.0
	16495367	CHEMBL3778174	Inhibition of N-terminal His6-tagged recombinant human CK1gamma2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-9.0	CHEMBL2543	Homo sapiens	Activity	%	-9.0
Not Active	16506531	CHEMBL3776526	Inhibition of full length recombinant human His-tagged CSNK1G2 expressed in baculovirus expression system at 5 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393		Inhibition	%		CHEMBL2543	Homo sapiens	INH		
	16506532	CHEMBL3776527	Inhibition of full length recombinant human His-tagged CSNK1G2 expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	43.0	CHEMBL2543	Homo sapiens	INH	%	43.0
	16508136	CHEMBL3778174	Inhibition of N-terminal His6-tagged recombinant human CK1gamma2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-29.0	CHEMBL2543	Homo sapiens	Activity	%	-29.0
	16509113	CHEMBL3778174	Inhibition of N-terminal His6-tagged recombinant human CK1gamma2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-7.0	CHEMBL2543	Homo sapiens	Activity	%	-7.0
Not Active	16514114	CHEMBL3782162	Inhibition of partial length human CSNK1G2 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2543	Homo sapiens	INH		
	16527336	CHEMBL3789920	Inhibition of human CK1gamma2 at 10 uM	B	CC1(C)CCC(Nc2ncnc3c2nn2ccccc32)CC1		CHEMBL3787247	=	Inhibition	%	50.4	CHEMBL2543	Homo sapiens	INH	%	50.4
	16578352	CHEMBL3804611	Inhibition of full length wild type human CSNK1G2 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	60.0	CHEMBL2543	Homo sapiens	Activity	%	60.0
	16592316	CHEMBL3807324	Inhibition of recombinant CK1gamma2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1		CHEMBL118518	>	Inhibition	%	30.0	CHEMBL2543	Homo sapiens	INH	%	30.0
	16592317	CHEMBL3807324	Inhibition of recombinant CK1gamma2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1		CHEMBL3805194	>	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	16594900	CHEMBL3812239	Inhibition of full length human CSNK1G2 expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL2543	Homo sapiens	Activity	%	100.0
	16596830	CHEMBL3812035	Inhibition of full-length human CSNK1G2 expressed in bacterial system assessed as remaining enzyme activity at 1 uM by KINOMEscan assay	B	Cc1nc2cccc3c2nc1N[C@H](C)/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21		CHEMBL3809691	<	Activity	%	10.0	CHEMBL2543	Homo sapiens	Activity	%	10.0
	16614430	CHEMBL3817296	Inhibition of human CK1gamma2 at 1 uM using [KRRRAL[pS]VASLPGL] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-13.0	CHEMBL2543	Homo sapiens	INH	%	-13.0
	16618259	CHEMBL3817065	Inhibition of full length recombinant human His-tagged CK1gamma2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	16654128	CHEMBL3829286	Inhibition of human CK1gamma2 (1 to 415 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	92.0	CHEMBL2543	Homo sapiens	Activity	%	92.0
Inactive	17894295	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894296	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894297	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894298	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894299	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894300	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894301	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894302	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894303	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894304	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894305	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894306	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894307	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894308	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894309	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894310	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894311	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894312	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894313	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894314	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894315	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894316	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894317	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894318	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894319	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894320	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894321	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894322	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894323	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894324	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894325	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894326	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894327	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894328	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894329	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894330	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894331	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894332	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894333	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894334	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894335	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894336	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894337	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17894338	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	46.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	46.0
Inactive	17894339	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894340	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894341	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894342	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894343	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894344	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894345	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894346	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894347	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894348	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Active	17894349	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	=	Kd	nM	105.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	105.0
Inactive	17894350	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894351	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894352	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894353	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894354	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894355	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894356	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894357	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894358	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894359	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894360	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894361	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894362	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894363	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894364	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894365	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894366	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894367	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894368	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894369	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894370	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894371	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894372	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894373	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17894374	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1862.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	1862.0
Inactive	17894375	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894376	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894377	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894378	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894379	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894380	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894381	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894382	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894383	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894384	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894385	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894386	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894387	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894388	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894389	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894390	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894391	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894392	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894393	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894394	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894395	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894396	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894397	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894398	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894399	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Active	17894400	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	1711.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	1711.0
Uncertain	17894401	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1653.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	1653.0
Inactive	17894402	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894403	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894404	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894405	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894406	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894407	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894408	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894409	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894410	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894411	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894412	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894413	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894414	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894415	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894416	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894417	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894418	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894419	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894420	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894421	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894422	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894423	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894424	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894425	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894426	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894427	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894428	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894429	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894430	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894431	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894432	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894433	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894434	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894435	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894436	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894437	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894438	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894439	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894440	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894441	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894442	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894443	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894444	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894445	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894446	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17894447	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	265.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	265.0
Inactive	17894448	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894449	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894450	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894451	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894452	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894453	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894454	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894455	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894456	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894457	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894458	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894459	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894460	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894461	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894462	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894463	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894464	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894465	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894466	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894467	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894468	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894469	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894470	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894471	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894472	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894473	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894474	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894475	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894476	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894477	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894478	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894479	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894480	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894481	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894482	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894483	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894484	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894485	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894486	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894487	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894488	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17894489	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
Active	17894490	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	968.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	968.0
Uncertain	17894491	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	Kd	nM	514.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	514.0
Inactive	17894492	CHEMBL3991678	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2543	Homo sapiens	Kd apparent	nM	30000.0
	17964889	CHEMBL3994998	Inhibition of full length human CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	73.0	CHEMBL2543	Homo sapiens	Activity	%	73.0
	17979242	CHEMBL3998047	Inhibition of full length recombinant human His-tagged CK1gamma2 expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	6.0	CHEMBL2543	Homo sapiens	INH	%	6.0
	18007223	CHEMBL4003431	Inhibition of CK1 gamma2 (unknown origin) assessed as residual activity at 1 uM relative to control	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)c1		CHEMBL4082278	=	Activity	%	10.0	CHEMBL2543	Homo sapiens	Activity	%	10.0
	18074011	CHEMBL4015993	Inhibition of CK1gamma2 in human THP1 cell lysate at 200 nM	B	CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F		CHEMBL4081711	>	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	18114415	CHEMBL4025079	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	94.0	CHEMBL2543	Homo sapiens	Activity	%	94.0
	18153112	CHEMBL4034304	Inhibition of CK1g2 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-23.1	CHEMBL2543	Homo sapiens	INH	%	-23.1
	18203603	CHEMBL4043890	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL2543	Homo sapiens	Activity	%	100.0
	18211591	CHEMBL4045666	Inhibition of CK1g2 labeling at conserved Lys1 (DVKPENFLVGRPGTK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-38.2	CHEMBL2543	Homo sapiens	INH	%	-38.2
	18211813	CHEMBL4045909	Inhibition of CK1g2 labeling at conserved Lys1 (DVKPENFLVGRPGTK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-23.0	CHEMBL2543	Homo sapiens	INH	%	-23.0
	18232152	CHEMBL4050354	Inhibition of human CK1gamma2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	86.0	CHEMBL2543	Homo sapiens	Activity	%	86.0
	18253767	CHEMBL4055168	Inhibition of wild-type human full length CK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL2543	Homo sapiens	Activity	%	100.0
	18253768	CHEMBL4055168	Inhibition of wild-type human full length CK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	82.0	CHEMBL2543	Homo sapiens	Activity	%	82.0
	18265760	CHEMBL4057210	Inhibition of Casein kinase 1g2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.7	CHEMBL2543	Homo sapiens	INH	%	0.7
	18265967	CHEMBL4057417	Inhibition of Casein kinase 1g2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	1.0	CHEMBL2543	Homo sapiens	INH	%	1.0
	18282019	CHEMBL4119974	Inhibition of CK1gamma2 (unknown origin) at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	4.3	CHEMBL2543	Homo sapiens	INH	%	4.3
	18282338	CHEMBL4119974	Inhibition of CK1gamma2 (unknown origin) at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	7.1	CHEMBL2543	Homo sapiens	INH	%	7.1
	18282849	CHEMBL4120434	Inhibition of CK1-gamma2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.7	CHEMBL2543	Homo sapiens	INH	%	0.7
	18283069	CHEMBL4120654	Inhibition of CK1-gamma2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	3.3	CHEMBL2543	Homo sapiens	INH	%	3.3
	18283289	CHEMBL4120874	Inhibition of CK1-gamma2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	2.3	CHEMBL2543	Homo sapiens	INH	%	2.3
	18407898	CHEMBL4151454	Inhibition of human CSNK1G2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	30.0	CHEMBL2543	Homo sapiens	Activity	%	30.0
	18407939	CHEMBL4151454	Inhibition of human CSNK1G2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12		CHEMBL4173266	=	Activity	%	18.0	CHEMBL2543	Homo sapiens	Activity	%	18.0
	18407984	CHEMBL4151454	Inhibition of human CSNK1G2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	19.0	CHEMBL2543	Homo sapiens	Activity	%	19.0
	18440145	CHEMBL4156969	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	82.0	CHEMBL2543	Homo sapiens	Activity	%	82.0
	18449843	CHEMBL4178082	Inhibition of human CK1gamma2 (1 to 415 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	113.0	CHEMBL2543	Homo sapiens	Activity	%	113.0
	18484585	CHEMBL4185748	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	86.0	CHEMBL2543	Homo sapiens	Activity	%	86.0
	18485036	CHEMBL4185748	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	97.0	CHEMBL2543	Homo sapiens	Activity	%	97.0
	18489503	CHEMBL4187244	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	95.0	CHEMBL2543	Homo sapiens	Activity	%	95.0
	18507847	CHEMBL4190915	Inhibition of recombinant human CK1gamma2 (18 to end residues) at 1 uM using KRRRALS(p)VASLPGL s substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	18.0	CHEMBL2543	Homo sapiens	INH	%	18.0
	18653701	CHEMBL4230053	Inhibition of CK1-gamma2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	1.0	CHEMBL2543	Homo sapiens	INH	%	1.0
	18653702	CHEMBL4230053	Inhibition of CK1-gamma2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	2.0	CHEMBL2543	Homo sapiens	INH	%	2.0
	18655587	CHEMBL4230648	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	99.0	CHEMBL2543	Homo sapiens	Activity	%	99.0
	18663779	CHEMBL4232883	Inhibition of full length human CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	76.0	CHEMBL2543	Homo sapiens	Activity	%	76.0
	18663996	CHEMBL4232980	Binding affinity to full length human CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2543	Homo sapiens	Kd	uM	5.0
	18697624	CHEMBL4254297	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	90.0	CHEMBL2543	Homo sapiens	Activity	%	90.0
	18751145	CHEMBL4263769	Inhibition of CK1-GAMMA2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-1.0	CHEMBL2543	Homo sapiens	INH	%	-1.0
	18751666	CHEMBL4264237	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	73.0	CHEMBL2543	Homo sapiens	Activity	%	73.0
	18857906	CHEMBL4307752	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	91.0	CHEMBL2543	Homo sapiens	Activity	%	91.0
	18892844	CHEMBL4314810	Inhibition of recombinant human CK1gamma2 (18 to end residues) assessed as residual activity at 10 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	104.5	CHEMBL2543	Homo sapiens	Activity	%	104.5
Not Determined	18929792	CHEMBL4325344	Inhibition of recombinant full-length human His-tagged CSNK1G2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133		IC50			CHEMBL2543	Homo sapiens	IC50		
	18929807	CHEMBL4325359	Inhibition of recombinant full-length human His-tagged CSNK1G2 expressed in baculovirus expression system at 1000 nM by Z'-LYTE assay relative to control	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133	=	Inhibition	%	87.0	CHEMBL2543	Homo sapiens	INH	%	87.0
	18937829	CHEMBL4327638	Inhibition of human CK1gamma2 assessed as residual activity at 1 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.64	CHEMBL2543	Homo sapiens	Activity	%	97.64
	18937830	CHEMBL4327638	Inhibition of human CK1gamma2 assessed as residual activity at 1 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	101.19	CHEMBL2543	Homo sapiens	Activity	%	101.19
	18938485	CHEMBL4328005	Inhibition of human CK1gamma2 assessed as residual activity at 100 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2543	Homo sapiens	Activity	%	65.0
	18938860	CHEMBL4328369	Inhibition of human CK1gamma2 using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3070.0	CHEMBL2543	Homo sapiens	IC50	10'-6M	3.07
	18958823	CHEMBL4333342	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	74.0	CHEMBL2543	Homo sapiens	Activity	%	74.0
	18964179	CHEMBL4335026	Inhibition of recombinant human CK1gamma2 (18 to end residues) assessed as residual activity at 1 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	98.0	CHEMBL2543	Homo sapiens	Activity	%	98.0
	18964180	CHEMBL4335026	Inhibition of recombinant human CK1gamma2 (18 to end residues) assessed as residual activity at 1 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	94.0	CHEMBL2543	Homo sapiens	Activity	%	94.0
	18971843	CHEMBL4336853	Inhibition of recombinant human CK1gamma2 (18 to end residues) assessed as residual activity at 10 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	73.0	CHEMBL2543	Homo sapiens	Activity	%	73.0
	19005801	CHEMBL4344398	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c3ccnc(C)c3n(CCCC(N)=O)c2c1		CHEMBL4474836	=	Activity	%	83.0	CHEMBL2543	Homo sapiens	Activity	%	83.0
	19005802	CHEMBL4344398	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	19.0	CHEMBL2543	Homo sapiens	Activity	%	19.0
	19005803	CHEMBL4344398	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	30.0	CHEMBL2543	Homo sapiens	Activity	%	30.0
Not Active	19039838	CHEMBL4351784	Inhibition of recombinant human CK1gamma2 (18 to end residues) at 10 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2543	Homo sapiens	INH		
Active	19041064	CHEMBL4352325	Inhibition of human CK1gamma2 at 10 uM using KRRRAL[pS]VASLPGL as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2543	Homo sapiens	INH		
	19059525	CHEMBL4357826	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2543	Homo sapiens	Activity	%	100.0
	19090096	CHEMBL4365670	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	68.0	CHEMBL2543	Homo sapiens	Activity	%	68.0
	19091878	CHEMBL4366352	Inhibition of human CK1gamma2 at 100 nM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	1.74	CHEMBL2543	Homo sapiens	INH	%	1.74
	19144705	CHEMBL4377721	Inhibition of recombinant human CK1gamma2 (18 to end residues) at 1 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	20.0	CHEMBL2543	Homo sapiens	INH	%	20.0
	19147796	CHEMBL4379192	Inhibition of recombinant human CK1gamma2 (18 to end residues) using KRRRALS(p)VAS as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2543	Homo sapiens	IC50	uM	10.0
	19159353	CHEMBL4382457	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	74.0	CHEMBL2543	Homo sapiens	Activity	%	74.0
	19180996	CHEMBL4387207	Inhibition of recombinant full length human His-tagged CK1 gamma 2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-5 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	7.0	CHEMBL2543	Homo sapiens	INH	%	7.0
	19181222	CHEMBL4387207	Inhibition of recombinant full length human His-tagged CK1 gamma 2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-5 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	3.5	CHEMBL2543	Homo sapiens	INH	%	3.5
	19191654	CHEMBL4389176	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL2543	Homo sapiens	INH	%	100.0
	19191839	CHEMBL4389653	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL2543	Homo sapiens	INH	%	100.0
	19199943	CHEMBL4391279	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	68.0	CHEMBL2543	Homo sapiens	Activity	%	68.0
	19266374	CHEMBL4405324	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	19275958	CHEMBL4407961	Inhibition of recombinant human CK1gamma2 (18 to end residues) at 1 uM using KRRRALS(p)VAS as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	49.0	CHEMBL2543	Homo sapiens	INH	%	49.0
	20600498	CHEMBL4603450	Inhibition of recombinant human full-length His-tagged CSNK1G2 expressed in baculovirus expression system using FRET-labeled Ser/Thr 05 peptide as substrate measured after 1 hr in presence of ATP by Z'-lyte assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2543	Homo sapiens	IC50	uM	100.0
	22392024	CHEMBL4667119	Inhibition of recombinant human His-tagged full length CK1gamma1 expressed in baculovirus expression system using Ser/Thr 05 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	3.0	CHEMBL2543	Homo sapiens	INH	%	3.0
	22423715	CHEMBL4674433	Inhibition of human CK1gamma2 using KRRRAL[pS]VASLPGL as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	107.12	CHEMBL2543	Homo sapiens	Activity	%	107.12
	22423716	CHEMBL4674433	Inhibition of human CK1gamma2 using KRRRAL[pS]VASLPGL as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	90.47	CHEMBL2543	Homo sapiens	Activity	%	90.47
	22442113	CHEMBL4678910	Inhibition of CK1gamma2 (unknown origin) in presence of 5 mM ATP	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	IC50	nM	6660.0	CHEMBL2543	Homo sapiens	IC50	uM	6.66
	22843441	CHEMBL4720438	Inhibition of human CK1gamma2 assessed as residual activity using KRRRAL[pS]VASLPGL as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	95.98	CHEMBL2543	Homo sapiens	Activity	%	95.98
	22843792	CHEMBL4720778	Inhibition of human CK1gamma2 using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1370.0	CHEMBL2543	Homo sapiens	IC50	10^-6M	1.37
	22844668	CHEMBL4721343	Inhibition of CK1g2 (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	95.64	CHEMBL2543	Homo sapiens	Activity	%	95.64
	22886582	CHEMBL4728285	Binding affinity to CSNK1G2 (unknown origin)	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	=	Kd	nM	100.0	CHEMBL2543	Homo sapiens	Kd	nM	100.0
Not Active	22889500	CHEMBL4729019	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2543	Homo sapiens	INH		
	22935140	CHEMBL4739359	Binding affinity to wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	Nc1nc(NCc2ccccc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4742954	=	Activity	%	20.0	CHEMBL2543	Homo sapiens	Activity	%	20.0
	22943991	CHEMBL4742511	Inhibition of CSNK1G2 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	B	COCc1cc(C)nc2sc(C(N)=O)c(N)c12		CHEMBL4780986	=	Activity	%	73.0	CHEMBL2543	Homo sapiens	Activity	%	73.0
	22952793	CHEMBL4766730	Inhibition of recombinant human CK1gamma2 (18 to end residues) assessed as residual activity at 10 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	17.0	CHEMBL2543	Homo sapiens	Activity	%	17.0
	23120129	CHEMBL4804328	Inhibition of wild-type human full length CSNK1G2 (M1 to K415 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	Nc1ncc(-c2cc([N+](=O)[O-])ccc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4874241	=	Activity	%	4.0	CHEMBL2543	Homo sapiens	Activity	%	4.0
	23120320	CHEMBL4804369	Inhibition of CK1g2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	>	IC50	nM	90000.0	CHEMBL2543	Homo sapiens	IC50	uM	90.0
	23120321	CHEMBL4804369	Inhibition of CK1g2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	>	IC50	nM	90000.0	CHEMBL2543	Homo sapiens	IC50	uM	90.0
	23120322	CHEMBL4804369	Inhibition of CK1g2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	77100.0	CHEMBL2543	Homo sapiens	IC50	uM	77.1
	23120323	CHEMBL4804369	Inhibition of CK1g2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	84100.0	CHEMBL2543	Homo sapiens	IC50	uM	84.1
	23120324	CHEMBL4804369	Inhibition of CK1g2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	74500.0	CHEMBL2543	Homo sapiens	IC50	uM	74.5
	23120325	CHEMBL4804369	Inhibition of CK1g2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	IC50	nM	90000.0	CHEMBL2543	Homo sapiens	IC50	uM	90.0
	23121361	CHEMBL4804551	Inhibition of CK1g2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	>	Inhibition	%	90.0	CHEMBL2543	Homo sapiens	INH	%	90.0
	23121362	CHEMBL4804551	Inhibition of CK1g2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	>	Inhibition	%	90.0	CHEMBL2543	Homo sapiens	INH	%	90.0
	23121363	CHEMBL4804551	Inhibition of CK1g2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	75.0	CHEMBL2543	Homo sapiens	INH	%	75.0
	23121364	CHEMBL4804551	Inhibition of CK1g2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	75.0	CHEMBL2543	Homo sapiens	INH	%	75.0
	23121365	CHEMBL4804551	Inhibition of CK1g2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	50.0	CHEMBL2543	Homo sapiens	INH	%	50.0
	23121366	CHEMBL4804551	Inhibition of CK1g2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	Inhibition	%	90.0	CHEMBL2543	Homo sapiens	INH	%	90.0
	23122511	CHEMBL4804862	Inhibition of human CSNK1G2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	89.0	CHEMBL2543	Homo sapiens	Activity	%	89.0
	23123206	CHEMBL4805450	Inhibition of human CSNK1G2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	86.0	CHEMBL2543	Homo sapiens	Activity	%	86.0
	23123685	CHEMBL4805929	Inhibition of DNA-tagged human CSNK1G2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	93.0	CHEMBL2543	Homo sapiens	Activity	%	93.0
	23124502	CHEMBL4806467	Inhibition of human CSNK1G2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	77.0	CHEMBL2543	Homo sapiens	Activity	%	77.0
	23124503	CHEMBL4806467	Inhibition of human CSNK1G2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	69.0	CHEMBL2543	Homo sapiens	Activity	%	69.0
	23127963	CHEMBL4807796	Inhibition of CK1gamma2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2543	Homo sapiens	Activity	%	75.0
	23127964	CHEMBL4807796	Inhibition of CK1gamma2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2543	Homo sapiens	Activity	%	75.0
	23127965	CHEMBL4807796	Inhibition of CK1gamma2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2543	Homo sapiens	Activity	%	75.0
Not Active	23317346	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	87.0	CHEMBL2543	Homo sapiens	% Control	%	87.0
Not Active	23317814	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23318484	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	78.0	CHEMBL2543	Homo sapiens	% Control	%	78.0
Not Active	23318964	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	64.0	CHEMBL2543	Homo sapiens	% Control	%	64.0
Not Active	23319603	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23320076	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	96.3	CHEMBL2543	Homo sapiens	% Control	%	96.3
Not Active	23320754	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23321222	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	99.0	CHEMBL2543	Homo sapiens	% Control	%	99.0
Not Active	23321852	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23322320	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL2543	Homo sapiens	% Control	%	96.0
Not Active	23323009	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	88.0	CHEMBL2543	Homo sapiens	% Control	%	88.0
Not Active	23323477	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	95.0	CHEMBL2543	Homo sapiens	% Control	%	95.0
Not Active	23323975	CHEMBL4880594	CK1gamma2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	19.0	CHEMBL2543	Homo sapiens	% inhibition	%	19.0
Not Active	23324331	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23324966	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	87.0	CHEMBL2543	Homo sapiens	% Control	%	87.0
Not Active	23325434	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23326081	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23326549	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	82.0	CHEMBL2543	Homo sapiens	% Control	%	82.0
Not Active	23327249	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23327717	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	85.0	CHEMBL2543	Homo sapiens	% Control	%	85.0
Not Active	23328304	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	88.0	CHEMBL2543	Homo sapiens	% Control	%	88.0
Not Active	23328772	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23329297	CHEMBL4881004	CK1gamma2 (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	91.0	CHEMBL2543	Homo sapiens	% residual kinase activity	%	91.0
Not Active	23329718	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23330186	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	93.0	CHEMBL2543	Homo sapiens	% Control	%	93.0
Not Active	23330942	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	89.0	CHEMBL2543	Homo sapiens	% Control	%	89.0
Not Active	23331410	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23331997	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	77.6	CHEMBL2543	Homo sapiens	% Control	%	77.6
Not Active	23332465	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	95.4	CHEMBL2543	Homo sapiens	% Control	%	95.4
Not Active	23333181	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	94.6	CHEMBL2543	Homo sapiens	% Control	%	94.6
Not Active	23333820	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	98.0	CHEMBL2543	Homo sapiens	% Control	%	98.0
Not Active	23334288	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23335267	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	94.0	CHEMBL2543	Homo sapiens	% Control	%	94.0
Not Active	23335735	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	83.0	CHEMBL2543	Homo sapiens	% Control	%	83.0
Not Active	23336362	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23336830	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	96.0	CHEMBL2543	Homo sapiens	% Control	%	96.0
Not Active	23337558	CHEMBL4881929	CSNK1G2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.5	CHEMBL2543	Homo sapiens	% Ctrl	%	98.5
Not Active	23337911	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23338379	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	82.0	CHEMBL2543	Homo sapiens	% Control	%	82.0
Not Active	23338991	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	93.0	CHEMBL2543	Homo sapiens	% Control	%	93.0
Not Active	23339459	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	95.0	CHEMBL2543	Homo sapiens	% Control	%	95.0
Not Active	23340096	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23340564	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	89.0	CHEMBL2543	Homo sapiens	% Control	%	89.0
Not Active	23341221	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23341689	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23342305	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23342773	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23343246	CHEMBL4882431	CSNK1G2 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	61.0	CHEMBL2543	Homo sapiens	% Ctrl	%	61.0
Not Active	23343403	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	79.0	CHEMBL2543	Homo sapiens	% Control	%	79.0
Not Active	23343871	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	90.0	CHEMBL2543	Homo sapiens	% Control	%	90.0
Not Active	23344509	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23345082	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	90.0	CHEMBL2543	Homo sapiens	% Control	%	90.0
Not Active	23345550	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	63.0	CHEMBL2543	Homo sapiens	% Control	%	63.0
Not Active	23346127	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	94.5	CHEMBL2543	Homo sapiens	% Control	%	94.5
Not Active	23346596	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23347204	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23347687	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23348266	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23348734	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23349321	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	99.0	CHEMBL2543	Homo sapiens	% Control	%	99.0
Not Active	23349939	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23350407	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23351012	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23351480	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23352009	CHEMBL4882700	CSNK1G2 (CK1 gamma 2) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	2.401	CHEMBL2543	Homo sapiens	% Inhibition	%	2.4009
Not Active	23352504	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23352972	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23353854	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23354322	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23355054	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	94.0	CHEMBL2543	Homo sapiens	% Control	%	94.0
Not Active	23355522	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	86.0	CHEMBL2543	Homo sapiens	% Control	%	86.0
Not Active	23356158	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23356626	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23357235	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23357882	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	92.0	CHEMBL2543	Homo sapiens	% Control	%	92.0
Not Active	23358350	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23358936	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	97.2	CHEMBL2543	Homo sapiens	% Control	%	97.2
Not Active	23359534	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	99.0	CHEMBL2543	Homo sapiens	% Control	%	99.0
Not Active	23360002	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23360587	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23361055	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	88.0	CHEMBL2543	Homo sapiens	% Control	%	88.0
Not Active	23361628	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23362164	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	79.0	CHEMBL2543	Homo sapiens	% Control	%	79.0
Not Active	23362632	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	82.0	CHEMBL2543	Homo sapiens	% Control	%	82.0
Not Active	23364274	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	80.0	CHEMBL2543	Homo sapiens	% Control	%	80.0
Not Active	23364742	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23365481	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	92.0	CHEMBL2543	Homo sapiens	% Control	%	92.0
Not Active	23366024	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	83.0	CHEMBL2543	Homo sapiens	% Control	%	83.0
Not Active	23366614	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	94.0	CHEMBL2543	Homo sapiens	% Control	%	94.0
Not Active	23367082	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	96.0	CHEMBL2543	Homo sapiens	% Control	%	96.0
Not Active	23367516	CHEMBL4883869	CK1-gamma2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	98.0	CHEMBL2543	Homo sapiens	% Residual activity with Skepinone-L	%	98.0
Not Active	23367960	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	96.0	CHEMBL2543	Homo sapiens	% Control	%	96.0
Not Active	23368428	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	98.0	CHEMBL2543	Homo sapiens	% Control	%	98.0
Not Active	23369027	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	96.0	CHEMBL2543	Homo sapiens	% Control	%	96.0
Not Active	23369495	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23370019	CHEMBL4884263	CK1gamma2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	98.0	CHEMBL2543	Homo sapiens	% residual kinase activity	%	98.0
Not Active	23370463	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	97.0	CHEMBL2543	Homo sapiens	% Control	%	97.0
Not Active	23370931	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	95.0	CHEMBL2543	Homo sapiens	% Control	%	95.0
Not Active	23371740	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	70.0	CHEMBL2543	Homo sapiens	% Control	%	70.0
Not Active	23372208	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	82.0	CHEMBL2543	Homo sapiens	% Control	%	82.0
	23372712	CHEMBL4884677	CK1gamma2(C1G2LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2543	Homo sapiens	pIC50		6.0
	23373121	CHEMBL4884968	CK1gamma2(C1G2LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2543	Homo sapiens	pIC50		6.0
	23373482	CHEMBL4885259	CK1gamma2(C1G2LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2543	Homo sapiens	pIC50		6.0
Not Active	23374942	CHEMBL4885936	CK1_gamma2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	5.0	CHEMBL2543	Homo sapiens	% Inhibition	%	5.0
Not Active	23375635	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	88.0	CHEMBL2543	Homo sapiens	% Control	%	88.0
Not Active	23376103	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23376680	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	74.0	CHEMBL2543	Homo sapiens	% Control	%	74.0
Not Active	23377150	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	88.0	CHEMBL2543	Homo sapiens	% Control	%	88.0
Not Active	23378008	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	87.0	CHEMBL2543	Homo sapiens	% Control	%	87.0
Not Active	23378476	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23379643	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	91.0	CHEMBL2543	Homo sapiens	% Control	%	91.0
Not Active	23380111	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	76.0	CHEMBL2543	Homo sapiens	% Control	%	76.0
Not Active	23380805	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23381453	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	90.0	CHEMBL2543	Homo sapiens	% Control	%	90.0
Not Active	23381921	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	91.0	CHEMBL2543	Homo sapiens	% Control	%	91.0
Not Active	23382545	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	99.0	CHEMBL2543	Homo sapiens	% Control	%	99.0
Not Active	23383013	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL2543	Homo sapiens	% Control	%	100.0
Not Active	23383751	CHEMBL4887395	CSNK1G2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	96.0	CHEMBL2543	Homo sapiens	% Ctrl	%	96.0
Not Active	23383752	CHEMBL4887395	CSNK1G2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	94.0	CHEMBL2543	Homo sapiens	% Ctrl	%	94.0
Not Active	23384225	CHEMBL4887820	CK1gamma2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	12.38	CHEMBL2543	Homo sapiens	% inhibition	%	12.38
Not Active	23384928	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	93.0	CHEMBL2543	Homo sapiens	% Control	%	93.0
Not Active	23385395	CHEMBL4879652	KinomeScan assay: inhibition of CSNK1G2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	84.0	CHEMBL2543	Homo sapiens	% Control	%	84.0
